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Cardiac tissue engineering aims to create functional tissue constructs in order to 
reestablish the function and structure of a damaged heart muscle using cells together with 
biomaterial scaffolds. One of the challenges is the cell source, because adult human 
cardiomyocytes (CMs) are difficult to obtain for study. However, CMs can be 
differentiated from pluripotent stem cells, one option being the human induced 
pluripotent stem cell (hiPSC). One of the main challenges in using hiPSC derived CMs 
(hiPSC-CMs) is that when cultured in normal in vitro conditions, they do not establish all 
the functional and morphological properties of adult CMs. The aim of this study was to 
produce structurally more mature hiPSC-CMs by culturing them on polyethylene 
terephthalate (PET) textiles. 
The hiPSCs were differentiated into CMs by END-2 method. The resulted hiPSC-CMs 
were cultured on gelatin coated PET textiles for 11 days. Control hiPSC-CMs were 
cultured on gelatin coated coverslips. The primary analyzing methods used in this study 
were immunocytochemistry and fluorescence microscopy. The cells were labeled with 
antibodies against sarcomeric proteins and also with live/dead stainings. From 
immunostained images, hiPSC-CM’s shape, multinucleation, and sarcomere 
organization, orientation and length were analyzed. 
The structural maturation of hiPSC-CMs was evaluated by comparing cells cultured on 
PET textiles to the cells cultured on coverslips. Even though the amount of cells attached 
on the textiles was very small, it was found out, that the cells grown on textiles were more 
adult-like in shape, the sarcomeres were more organized, and the amount of 
multinucleated cells was higher. However, there was no significant difference in 
sarcomere lengths. 
Based on the results, it can be argued that the cells grown on textiles were structurally 
more mature than the cells grown on coverslips. However, the small amount of cells 
attached on the textiles was a challenge. In future studies, the cell attachment should be 
improved, for example by using a different coating, in order to maintain more cells in the 
culture, thus making the analysis more reliable and reproducible. 
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Sydämen kudosteknologia tähtää vaurioituneen sydänlihaksen korjaamiseen soluista ja 
biomateriaaleista valmistetuilla funktionaalisilla kudosrakennelmilla. Yksi alan 
haasteista on solujen saatavuus, sillä aikuisen sydänlihassolujen hankkiminen 
tutkimustarkoituksiin on vaikeaa. Sydänlihassoluja voidaan kuitenkin erilaistaa 
pluripotenteista kantasoluista, kuten ihmisen uudelleen ohjelmoiduista kantasoluista 
(hiPS-soluista). Kun kantasoluista erilaistettuja sydänlihassoluja kasvatetaan in vitro -
olosuhteissa, niiden käyttöön liittyy haasteita, sillä ne eivät saavuta kaikkia aikuisen 
sydänlihassolujen funktionaalisia ja morfologisia ominaisuuksia. Tämän tutkimuksen 
tavoitteena oli tuottaa rakenteellisesti kypsempiä, aikuisen sydänlihassolun kaltaisia 
hiPS-soluista erilaistettuja sydänlihassoluja kasvattamalla niitä polyetyleenitereftalaatista 
(PET) valmistetun tekstiilin päällä. 
hiPS-solut erilaistettiin sydänlihassoluiksi END-2-menetelmällä. Näitä sydänlihassoluja 
kasvatettiin gelatiinilla pinnoitetuilla PET-tekstiileillä 11 päivän ajan. Kontrollinäytteinä 
käytettiin gelatiinilla pinnoitettujen peitinlasien päällä kasvatettuja hiPS-sydänsoluja. 
Ensisijaiset tutkimusmenetelmät olivat immunosytokemia ja fluoresenssimikroskopia. 
Immunovärjäyksillä saatiin visualisoitua sarkomeeriproteiineja, ja soluille tehtiin myös 
live/dead-värjäyksiä. Immunovärjätyistä kuvista analysoitiin solujen muotoa ja 
monitumaisuutta sekä sarkomeerien järjestäytyneisyyttä, orientaatiota ja pituutta. 
hiPS-soluista erilaistettujen sydänlihassolujen rakenteellista kypsymistä arvioitiin 
vertaamalla tekstiileillä ja peitinlaseilla kasvatettuja soluja keskenään. Vaikka tekstiileille 
tarttuneiden solujen määrä oli vähäinen, havaittiin, että tekstiileillä kasvaneiden solujen 
muoto, sarkomeerien orientaatio ja monitumaisuus muistuttivat enemmän aikuisen 
sydänlihassoluja kuin peitinlaseilla kasvaneiden. Sen sijaan merkittävää eroa 
sarkomeerien pituuksissa ei havaittu. 
Tulosten perusteella voidaan väittää, että tekstiileillä kasvatetut solut kehittyivät 
rakenteellisesti enemmän aikuisen sydänlihassolujen kaltaisiksi kuin solut, joita 
kasvatettiin peitinlaseilla. Tutkimuksen haasteena oli tekstiileille tarttuneiden solujen 
vähäinen määrä. Tulevaisuudessa solujen tarttumista tulisi parantaa esimerkiksi 
käyttämällä erilaista pinnoitetta, jotta enemmän soluja säilyisi viljelmässä ja analyyseistä 
tulisi luotettavampia ja toistettavampia. 
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1. INTRODUCTION 
Cardiac tissue engineering is a growing branch of research in the field of tissue 
engineering. One of the challenges in the research area has been the cell source of 
cardiomyocytes, because adult human cardiomyocytes (CMs) are difficult to obtain for 
study. An option is to use stem cells and differentiate them into cardiomyocytes. Human 
embryonic stem cells are pluripotent stem cells, which have the potential to differentiate 
into all human cells found in adults. However, certain technical and ethical problems limit 
the use of human embryonic stem cells as a cell source. (Chen et al. 2008; van Blitterswijk 
2008, p. 7) 
Another stem cell type capable of forming adult cell lines is the human induced 
pluripotent stem cell (hiPSC). These cells have been made by reprogramming adult 
human cells back into a pluripotent state. The advantages of hiPSCs include the lack of 
ethical problems associated with embryonic stem cells, as well as the production of 
patient and disease specific cells is possible. The hiPSC-CMs have the same genome as 
the donor. (Takahashi et al. 2007) This can be utilized in the field of cardiac tissue 
engineering, for example, for drug screening and disease modeling of inherited cardiac 
diseases (Khan et al. 2013). 
One of the main challenges in using hiPSC derived cardiomyocytes (hiPSC-CMs) is that 
when cultured in normal in vitro conditions, they do not establish all the functional and 
morphological properties of adult CMs (Yang et al. 2014; Rao et al. 2013). Instead, their 
properties resemble more those of the human fetal CMs (Tzatzalos et al. 2016). The 
maturation of hiPSC-CMs is important for several reasons, including that mature cells 
would be more useful in drug screening and disease modeling, because they reflect the 
physiology of the adult CMs better. Also, in myocardial repair, the hiPSC-CMs 
introduced to the human body should have properties which resemble those of native 
cardiac muscle. (Yang et al. 2014) 
This thesis concentrated on the structural maturation of hiPSC-CMs. While hiPSC-CMs 
are circular or irregularly shaped, the appearance of adult CMs is rectangular or rod-like, 
and adult CMs are significantly bigger than the hiPSC-CMs. Also, the smallest contractile 
units of CMs, sarcomeres, are disorganized in hiPSC-CMs, whereas the sarcomere 
structures in adult CMs are highly organized. (Yang et al. 2014) 
The purpose of this thesis was to investigate whether the structural maturation of hiPSC-
CMs could be enhanced by growing them on different PET textiles. The hypothesis was, 
that the cells would grow along the fibers of the textiles, and thus become more rod-like 
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in shape. Also, the sarcomere structures were expected to become more organized during 
the shape transition. The main tool for evaluating the maturation was staining the cells 
grown on PET textiles and imaging them using fluorescence microscopy. 
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2. LITERATURE REVIEW 
2.1 Cardiac Tissue Engineering 
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. In 2012, 
approximately 31 % of all global deaths were caused by a CVD. (World Health 
Organization 2015) Due to this enormous clinical need, cardiac tissue engineering has 
become an important branch of research in the field of tissue engineering. The aim in 
cardiac tissue engineering is to create functional tissue constructs in order to reestablish 
the function and structure of a damaged heart muscle using stem cells and scaffolds made 
of biomaterials. (Chen et al. 2008; Vunjak-Novakovic et al. 2010) 
The discovery and development of induced pluripotent stem cell (iPSC) technology has 
enabled the use of patient-specific stem cells for research. In the case of cardiac tissue 
engineering, iPSCs (which will be further discussed later) can be differentiated into 
spontaneously beating cells of the heart, cardiomyocytes (CMs). iPSC-derived 
cardiomyocytes (iPSC-CMs) can be characterized by various methods, and both healthy 
and disease-specific CMs can be produced. (Tzatzalos et al. 2016; Mummery et al. 2012) 
However, hiPSC-CMs cultured in normal in vitro conditions display immature phenotype 
(Rao et al. 2013). 
In cardiac tissue engineering, CMs are often cultured on some kind of a biomaterial 
scaffold. The scaffold should mimic the functions of extracellular matrix (ECM) of CMs, 
at least partly. (Chen et al. 2008) For example, it should support cell attachment, growth, 
and differentiation, have sufficient mechanical properties, and provide porous structure 
for the diffusion of nutrients and metabolites (Chan & Leong 2008). Also, in the case of 
hiPSC-CMs, the use of biomaterials provide one possible approach to promoting hiPSC-
CMs’ maturation in vitro. Engineered heart tissue and iPSC-CM technologies are utilized, 
for example, for drug testing and disease modeling. Also, it is probable, that iPSC-CMs 
can be used as a tool for repairing the injured heart in the future. (Tzatzalos et al. 2016; 
Mummery et al. 2012) 
The following subchapters include basics of cell culturing (Subchapter 2.1.1), a brief 
description of the human heart and cardiomyocytes (Subchapter 2.1.2), and an 
introduction to induced pluripotent stem cells (Subchapter 2.1.3) and human induced 
pluripotent stem cell derived cardiomyocytes (Subchapter 2.1.4). Biomaterials 
(Subchapter 2.2) and textiles as tissue engineering scaffolds (Subchapter 2.3) are 
discussed in their own sections after these topics. Also, a brief literature review of 
previous studies made by other research groups is included (Subchapter 2.4). 
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2.1.1 Cell Culturing 
The general term for cell harvesting and the subsequent growth and maintenance of the 
cells in an artificial environment is a cell culture. When cultured in vitro, cells have the 
same basic needs as cells grown within an organism, for example the human body. 
(Ratner et al. 2013, p. 408) In the human body, blood is responsible for carrying nutrients 
and waste products. In a cell culturing system, the nutrients are introduced to the cells via 
cell culture medium, which is an in vitro substitute for a biological fluid. (van Blitterswijk 
2008, pp. 328–329) In addition to nutrients (salts and amino acids), cell culture medium 
contains proteins and hormones (from added serum), a buffer (maintains pH balance), 
and an energy source (glucose). The byproducts of cellular metabolism are released into 
the medium as the cells are depleting medium’s ingredients. Thus, the culture medium 
must be changed regularly to maintain the optimal conditions. (Ratner et al. 2013, p. 408) 
Cell culturing systems are often categorized in static and dynamic systems. In static 
systems, the culture is not exposed to external forces, and the only effects are caused by 
interaction with the environment and by conduction and reaction processes within the 
system. By contrast, in dynamic cell culture systems, there are external forces involved. 
The system can have a mechanical, hydraulic, or pneumatic power input. (Eibl et al. 2009, 
p. 57) Different static cell culturing systems are illustrated in Figure 2.1. In order to 
enhance the ability of cell binding to the cell culture substrate, different kinds of coatings, 
for example gelatin or collagen, are often applied to the surfaces (van Blitterswijk 2008, 
p. 316). 
 
Figure 2.1. Different static cell culture systems with unenforced power input: (a) Petri 
dish, (b) T-flask, (c) multitray cell culture system, (d) culture bag, (e) static membrane 
flask bioreactor, and (f) multiwell plate. (Eibl et al. 2009, p. 59) 
Cell culture systems are incubated in a chamber, which is temperature-controlled and 
humidified. The temperature is kept at the temperature of the human body (37 °C), and 
the humidity is approximately 95 %. Also, carbon dioxide (CO2) is added to the incubator 
at a low concentration (5 %). CO2 helps maintain a pH of 7.0–7.4 by interacting with the 
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buffer in the culture medium. Since these culture conditions are also favorable for 
unwanted organisms (fungi, bacteria) to grow, contaminations are avoided by handling 
cells under a laminar hood using strict sterile methods. Also, anti-fungal and anti-bacterial 
substances are often added to the cell culture medium. (Ratner et al. 2013, pp. 408–409) 
In the human body, many organs have different cell types that act together as a team 
supporting each other. In some cases, the same idea is used in cell cultures in vitro: cells 
are co-cultured with another cell type. In co-cultures, so-called feeder cells are first seeded 
on a cell culturing system, e.g. Petri dish. Feeder cells are supporting cells from a rapidly 
growing cell line, for example a mouse cell line. When the Petri dish reaches the desired 
confluence, the cell proliferation is arrested by irradiation or by treating the cells with a 
mitosis arresting drug, Mitomycin. After that, the cells of interest can be seeded on top of 
the feeder cells. Feeder cells have many functions: processing of nutrients, detoxification, 
activation and deactivation of hormones and growth factors, and also acting as a 
supporting cell matrix. (van Blitterswijk 2008, p. 317) 
Feeder cells can be utilized, for example, in stem cell cultures, in which the feeder cells 
allow the continuous growth of stem cells while maintaining their undifferentiated state. 
Feeder cells provide nutrients and a surface to which the stem cells can attach. When not 
cultured on feeder cells, stem cells require a matrix for attachment and growth. (Amit et 
al. 2003) Feeder cells are also utilized in producing other cell types from stem cells. For 
example, hiPSCs can be differentiated into CMs by co-culturing them with mouse 
endodermal-like (END-2) cells, which secrete differentiation inducing factors into the 
culture medium. (Mummery et al. 2003; Passier et al. 2005) 
2.1.2 The Heart and Cardiomyocytes 
The primary task of the heart is to maintain blood pressure and circulation. In order to 
carry out this task properly, the heart muscle is specialized to produce a coordinated and 
rhythmic contraction. The heart receives oxygen-poor blood that returns from the tissues 
of the body via the venous circulation. The oxygen-poor blood is then sent to the lungs 
for oxygenation. Also, the heart must receive the oxygenated blood and send that blood 
via the arterial circulation to the rest of the body. This process of coordinated pumping of 
blood requires precise timing of the contractions of the four chambers of the human heart. 
(Matthews 2009, p. 191) 
The walls of a chamber consists of three layers: peri-, myo- and endocardium. 
Myocardium, the heart muscle, consists of cardiomyocytes and connective tissue. 
Cardiomyocytes contain dozens of parallel cylindrical elements, myofibrils. Each of these 
comprises repeating units, sarcomeres (Figure 2.2). (Sparrow & Schöck 2009; Boron & 
Boulpaep 2005, p. 232) 
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Figure 2.2. Sarcomere structure, adapted from (Pasqualini et al. 2015). A sarcomere is 
bordered by two Z-discs, and it consists of myosin-containing thick filaments and actin-
containing thin filaments. The thick filaments are anchored at the M-line, which lies 
half way between the Z-discs. 
A sarcomere is the smallest functional contractile unit of a muscle, and it consists of two 
types of myofilaments: myosin-containing thick filaments and actin-containing thin 
filaments. The thick filaments are anchored at the M-line and they lie between the thin 
filaments. Myofibrils are made up by stacking sarcomeres end to end and they have the 
diameter of a Z-disc. One sarcomere is bordered by two Z-discs, which the sarcomere 
shares with its neighboring sarcomeres. (Sparrow & Schöck 2009; Boron & Boulpaep 
2005, pp. 232–233) In adult cardiomyocytes, the sarcomere structures are highly 
organized, as seen in Figure 2.3. Also, the cells are rod-shaped or cylindrical, and they 
may contain multiple nuclei. (Robertson et al. 2013; Yang et al. 2014) 
 
Figure 2.3. Confocal microscopy image of single adult cardiomyocyte, adapted from 
(Severs 2000). The image shows myofibrils, which are seen as striations. The myofibrils 
are revealed by immunostaining with an antibody against α-actinin, a component found 
in the sarcomere Z-discs. 
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In the cardiac muscle contraction, the atria and the ventricles contract one after another. 
The electrical signals that trigger the cardiac muscle contraction originate in the 
pacemaker region of the heart, the sinoatrial (SA) node, which generates action potentials 
spontaneously and periodically. The SA node is located in the wall of the right atrium, 
and it sends action potentials to the cardiomyocytes of the right and left atria, making 
them contract. The excitation spreads and reaches the atrioventricular (AV) node, which 
is located in the lower part of the right atrium. From the AV node, the excitation 
propagates fast through the rest of the conducting system: the bundle of His, the right and 
left bundle branches, and finally, the Purkinje fibers, which transmit the action potentials 
to the cardiomyocytes of the ventricles. (Schmidt & Thews 2013, p. 360; Anna 2011, p. 
93) The electrical conduction system of the heart is illustrated in Figure 2.4. 
 
Figure 2.4. Electrical conduction system of the heart as seen in frontal section, adapted 
from (Schmidt & Thews 2013, p. 360). 
Cardiomyocytes must contract at the same time in order to pump blood. In cardiac muscle, 
the excitation spreads rapidly out from one cell to another, which enables the 
cardiomyocytes to contract simultaneously. The rapid spreading is enabled by specialized 
structures called intercalated discs. The process from electrical excitation of a 
cardiomyocyte to contraction of the cardiac muscle is called cardiac excitation-
contraction coupling. The underlying trigger for muscle contraction is a rise in the free 
intracellular Ca2+ concentration [Ca2+]i, which is briefly explained in the following 
paragraph. (Bers 2002; Matthews 2009, p. 193; Boron & Boulpaep 2005, p. 522) 
During heart muscle contraction, the thick filaments establish cross-bridges to the thin 
filaments. The making and breaking of cross-bridges results in drawing the thin filaments 
over the thick filaments, which causes the muscle contraction. As the action potential 
travels, it activates Ca2+ channels which allow the Ca2+ ions to enter the cell. The entry of 
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the Ca2+ ions triggers Ca2+ ion release from the sarcoplasmic reticulum, an organelle 
which functions as a storage for intracellular Ca2+ ions. Because of the Ca2+ influx and 
release, the free intracellular [Ca2+]i rises, after which the Ca
2+ ions are able to bind to the 
thin filament protein troponin C. This allows the thick filament to form cross-bridges to 
the thin filament. Relaxation occurs when [Ca2+]i decreases and Ca
2+ ions dissociate from 
troponin. (Bers 2002; de Tombe 2003) 
2.1.3 Induced Pluripotent Stem Cells 
Stem cells are cells, which have the ability to produce new stem cells (self-renewal) and 
any other cell type of the body (differentiation). A term “potency” defines the 
differentiation capacity of a stem cell. The used terms are totipotent, pluripotent, 
multipotent, oligopotent and unipotent stem cells. Totipotent stem cells are able to form 
an entire organism. The cells that are considered totipotent, are the fertilized oocyte and 
the cells that are formed in the first cleavage divisions. Pluripotent stem cells can form 
all three germ layers (ectoderm, mesoderm and endoderm) including germ cells. 
However, pluripotent stem cells (PSCs) are not able to form extra-embryonic tissue (e.g. 
placenta). Pluripotent cells are found in the blastocyst, and when brought into a cell 
culture, they are referred to as embryonic stem cells (ESCs). Multipotent stem cells are 
able to form multiple cell types. For example, mesenchymal stem cells have the ability to 
differentiate into bone, cartilage and adipose cells. Oligopotent stem cells are able to form 
two or more lineages. For instance, neural stem cells, which can differentiate into a subset 
of neurons in the brain, are oligopotent stem cells. Lastly, unipotent stem cells can form 
cells from a single lineage. (van Blitterswijk 2008, p. 3) 
Even though human embryonic stem cells (hESCs) are a promising cell source for disease 
and injury treatments, there are still some problems in their use in patients. Technical 
problems include immune rejection of transplanted hESCs, and there are also ethical 
problems in the use of human embryos as a cell source. (van Blitterswijk 2008, p. 7) In 
order to isolate hESCs, the human blastocyst has to be destructed, and that is an issue 
which has induced multiple debates concerning the ethics of hESC derivation. Also, 
regulations concerning the usage and research of hESCs have been set across the world. 
In the European Union, the Court of Justice forbade the patenting of any process involving 
the destruction of human blastocyst in 2011. The regulation has caused concern for the 
scientific community because the investors might lose interest in the research using 
hESCs. (de Lázaro et al. 2014) The technical and ethical problems, among others, led 
scientists to seek for other possibilities (van Blitterswijk 2008, p. 7). 
Induced pluripotent stem cells (iPSCs) were found by Shinya Yamanaka and 
collaborators who published the study in 2006. Yamanaka’s group was able to turn mouse 
fibroblasts back into a pluripotent state, and the resulting cells were called iPS cells. The 
results were achieved by genetically reprogramming fibroblasts by retroviral transduction 
of four transcription factors which are needed for the maintenance of embryonic stem 
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cells’ pluripotency. The four transcription factors were Oct-3/4, Sox2, c-Myc and Klf-4. 
(Takahashi & Yamanaka 2006) In 2007, Yamanaka’s research group published a study, 
where a similar approach was succesfully applied to human dermal fibroblasts. The study 
showed that human induced pluripotent stem cells (hiPSCs) can be generated by retroviral 
transduction of the same four transcription factors that were used in the generation of 
mouse iPSCs. (Takahashi et al. 2007). Also, a contemporaneous study accomplished the 
same result by using a different combination of transcription factors: OCT4, SOX2, 
NANOG, and LIN28 (Yu et al. 2007). 
At first, scientists were amazed by how remarkably similar iPSCs and ESCs were. After 
further studies, however, conflicting conclusions regarding the similarity of these cells 
were made. For example, some studies demonstrated that iPSC clones and ESC clones 
are difficult to distinguish and that their gene expression and DNA methylation are very 
similar – some studies concluded the opposite. In addition, different studies regarding the 
differentiation efficacy of iPSCs compared to that of ESCs reported different results. 
However, different properties of iPSCs produced in different laboratories depend on 
technical variables, such as different gene delivery methods and different laboratory 
culture conditions. Also, some differencies can be explained by uncontrollable stochastic 
events during reprogramming. (Yamanaka 2012; Bilic & Belmonte 2012) 
2.1.4 Human Induced Pluripotent Stem Cell Derived 
Cardiomyocytes 
Many laboratories have successfully differentiated hiPSCs to cardiomyocytes. These 
hiPSC derived cardiomyocytes (hiPSC-CMs) beat spontaneously in cell culture. They 
exhibit functional properties similar to the cardiomyocytes in the developing heart, and 
express ion channels and sarcomeric proteins which are expected from cardiomyocytes. 
(Yang et al. 2014) Cardiomyocytes can be differentiated from hiPSCs in several ways. 
For example, one option is a spontaneous differentiation of hiPSCs in embryoid bodies 
(EBs). EBs are three-dimensional multicellular aggregates formed by hiPSCs. The 
method is relatively simple and inexpensive, but the differentiation rate is low. Only a 
small part of the EBs form spontaneously beating areas. Also, cardiac differentiation can 
be achieved using defined growth factors. The idea is to activate or stimulate the signaling 
pathways which are responsible for cardiac differentiation during embryonic 
development in vivo. (Kujala et al. 2011; Kurosawa 2007; Acimovic et al. 2014) Yet 
another method is to co-culture hiPSCs with mouse endodermal-like (END-2) cells, in 
which the END-2 cells secrete differentiation inducing factors into the culture medium. 
(Mummery et al. 2003; Passier et al. 2005) 
hiPSC-CMs enable the use of patient specific cells: the CMs are derived from iPSCs, 
which in turn are produced from the patient’s own cells (e.g. fibroblasts). Thus, the 
hiPSC-CMs have the same genome as the patient. This can be utilized in cardiac tissue 
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engineering, since the hiPSC-CMs produced from a patient with inherited cardiac disease 
carry the same genetic mutation as the patient itself. These patient specific hiPSC-CMs 
have many applications. They can be used in drug screening, disease modeling, and 
hopefully in patient targeted cell therapy in the future. Also, hiPSC-CMs are a potentially 
unlimited source of human cardiomyocytes. (Khan et al. 2013) The problem in using 
hiPSC-CMs is that they do not exhibit all the functional and morphological characteristics 
of adult CMs when grown in normal 2-dimensional in vitro culture conditions (Yang et 
al. 2014; Rao et al. 2013). Instead, hiPSC-CMs’ gene expression, structural, and 
functional properties resemble more those of the human fetal CMs (Tzatzalos et al. 2016). 
There are many ways to evaluate the maturation of hiPSC-CMs. Firstly, cell morphology 
can be compared to that of adult CMs. For instance, shape and size, sarcomere alignment 
and cell-to-cell alignment can be compared. Secondly, functional assays can be used to 
study, for example, calcium transients, contraction, and electrophysiology of the cells. 
Finally, molecular assays can be utilized in gene expression analysis. (Tzatzalos et al. 
2016) This study will concentrate on the morphological maturation of hiPSC-CMs. Some 
morphological differences between hiPSC-CMs and adult CMs are given in Table 2.1. 
Table 2.1. Morphological differences between hiPSC-CMs and adult cardiomyocytes 
(Yang et al. 2014; Mummery et al. 2012; Robertson et al. 2013). 
Parameters hiPSC-CMs Adult CMs 
Cell shape Circular, irregular Rod-shaped, rectangular 
Cell size Small (≈ 300 μm2) Large (≈ 1500 μm2) 
Sarcomere structure Disarrayed Highly organized 
Sarcomere length ≈ 1.6 μm ≈ 2.2 μm 
Multinucleation Mononucleated ≈ 25 % multinucleated 
 
As seen in Table 2.1, hiPSC-CMs differ from adult CMs in cell shape and size, sarcomere 
structure and length and in the number of nuclei. hiPSC-CMs are circular and irregularly 
shaped, whereas adult CMs are rod-shaped. Also, hiPSC-CMs are significantly smaller 
than adult CMs. According to Robertson et al. (2013), adult CMs can be 150 × 10 μm, 
whereas hiPSC-CMs are usually 30 × 10 μm at most. The sarcomere structures in hiPSC-
CMs are disarrayed and the sarcomere length is approximately 1.6 μm. By contrast, in 
adult CMs they are highly organized and the sarcomeres are longer, approximately 2.2 
μm m. (Robertson et al. 2013; Yang et al. 2014; Mummery et al. 2012)  
The studies regarding multinucleation of CMs are not unanimous, and it is not clear 
whether the multinucleation of CMs is a maturation marker or not. According to 
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Robertson et al. (2013), hiPSC-CMs are mononucleated, whereas most adult CMs have 
multiple nuclei. Another source claims that the estimated percentage of binucleation of 
mature CMs is 25 %, which is reached a few months after birth (Yang et al. 2014). In 
contrary, some sources state that fully differentiated CMs only have a single nucleus 
(Sparrow & Schöck 2009). 
There are several reasons why the maturation of hiPSC-CMs is important. Firstly, adult 
human cardiomyocytes are difficult to obtain for study. Secondly, mature cells would be 
more useful in disease modeling and drug screening, since they reflect the physiology of 
the adult CMs better. Finally, when introducing cells into the human body in myocardial 
repair, hiPSC-CMs should have electric and mechanical properties which resemble the 
properties of native cardiac muscle. Mature cardiomyocytes would expectedly have 
enhanced contractile performance. Also, there should be a smaller risk of arrhythmia. 
(Yang et al. 2014) 
2.2 Biomaterials 
The definition of a biomaterial was given by The National Institutes of Health Consensus 
Development Conference, which defined a biomaterial as “any substance (other than a 
drug) or combination of substances, synthetic or natural in origin, which can be used for 
any period of time, as a whole or as a part of a system which treats, augments, or replaces 
any tissue, organ, or function of the body” (Boretos & Eden 1984, pp. 232–233). In other 
words, a biomaterial is a material which is able to exist and perform in contact with living 
tissues or tissue components without causing an unacceptable amount of harm to them. 
This ability of a biomaterial is often referred to as biocompatibility. (van Blitterswijk 
2008, p. 256) The Williams Dictionary of Biomaterials (Williams 1999, p. 40) defines 
biocompatibility as “the ability of a material to perform with an appropriate host response 
in a specific application.” 
Biomaterials are found in all material classes: metals, polymers, ceramics, and 
composites. Also, biomaterials can be classified into different types, for example 
bioactive, biostable, and biodegradable. Bioactive materials promote the bonding of a 
living tissue to the material. (Patel & Gohil 2012; Dee et al. 2002) Biostable materials are 
able to resist structural and chemical degradation within a biological environment. In 
practice, all materials are subjected to some changes when placed in a biological 
environment. The term biostable refers to situations, where the changes have no clinical 
consequences. (Williams 1999, p. 44) Biodegradable materials degrade and are replaced 
by regenerated tissue when placed in the human body (Dee et al. 2002).  
Polymers are the most used material class in the biomedical field because of their many 
unique properties, such as high porosity with a very small pore size and high surface-to-
volume ratio. The main types of polymers used as biomaterials are naturally occurring 
polymers, synthetic biodegradable, and synthetic biostable polymers. Naturally occurring 
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polymers include proteins (gelatin, collagen), polysaccharides (cellulose, chitin), and 
polynucleotides (DNA, RNA). Naturally occurring polymers have bioactive properties. 
Also, they can be considered as the first clinically used biodegradable materials. 
However, synthetic polymers have many advantages over naturally occurring polymers. 
For example, their properties, such as mechanical characteristics, porosity, and 
degradation time, can be tailored for different applications. In addition, they are often 
cheaper, they can be produced in large quantities, and their shelf time is longer. 
(Dhandayuthapani et al. 2011) Biodegradable polymers can be classified into 
hydrolytically and enzymatically degradable polymers, since the biodegradation of 
polymeric biomaterials occurs via cleavage of hydrolytically or enzymatically sensitive 
bonds. Due to their minimal patient-to-patient and site-to-site variations, hydrolytically 
degradable polymers are usually more favorable as implants compared to enzymatically 
degradable polymers. (Nair & Laurencin 2007) 
In tissue engineering applications, biodegradable polymers are often more favorable than 
biostable polymers, because many permanent implants have long-term biocompatibility 
issues. Also, there is no need for a second surgery when using biodegradable materials. 
(Nair & Laurencin 2007) However, it should be mentioned that biocompatibility issues 
exist with biodegradable materials, too. The problems include pro-inflammatory products 
released during the degradation process. Thus, in the cases where it is acceptable for the 
material residue to remain in the body after the tissue regeneration, biostable materials 
can be considered as one option for the application. (van Blitterswijk 2008, p. 269) Some 
biostable polymers, such as polyethylene terephthalate (PET), have been investigated also 
for cardiac tissue engineering. One typical application is cardiovascular grafting. (Chen 
et al. 2008) 
2.3 Textiles as Tissue Engineering Scaffolds 
Textile materials can be produced in many different forms, including woven, nonwoven, 
and knitted fabrics, and monofilament and multifilament yarns. Unlike many other 
polymeric materials, textiles offer compliance and porosity within the material structure, 
and they can meet the needs of applications, which require a combination of flexibility, 
strength, and in some cases moisture and air permeability. Because of their ability to form 
a wide range of different kinds of structures with different kinds of properties, textile 
materials are an especially attractive option for the production of tissue engineering 
scaffolds. (Alagirusamy & Das 2010, pp. 452–453) 
In addition to biocompatibility, two important aspects of scaffold design are the 
mechanical and microstructural properties, both of which can be tailored by using 
different textile techniques (Tao 2001, p. 298). In this study, cardiomyocytes were 
cultured on woven textile structures. Thus, some microstructural and mechanical 
properties of scaffolds made by weaving are given in Table 2.2. The weaving process is 
further discussed later. 
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Table 2.2. Microstructural and mechanical properties of woven textile scaffolds (Tao 
2001, p. 300; 304). 
Microstructural  Mechanical 
Pore size (μm) 0.5−1000 Stiffness High 
Porosity (%) 30−90 Strength High 
Pore distribution Uniform Structural stability Excellent 
Pore connectivity Excellent Isotropy Anisotropic (properties 
depend on direction of 
measurement) 
 
The optimum design of a scaffold depends on which kind of a tissue it is prepared for. 
Ideally, the mechanical properties of a scaffold should match those of the surrounding 
tissues, but the scaffold must also be strong enough to withstand surgical handling during 
implantation. The microstructural properties include porosity, pore size and distribution, 
and pore interconnectivity. For example, cellular penetration and diffusion of nutrients 
and waste products depend on these factors. (Tao 2001, p. 298; O'Brien 2011) 
Textiles as tissue engineering scaffolds have been studied for many applications. For 
example, Karamuk et al. (1999) studied woven PET textile scaffolds coated with thin poly 
lactic-co-glycolic acid (PLGA) film for liver cell culture. The fiber diameters were not 
mentioned in the article, but the mesh sizes varied from 50 μm to 800 μm. It was found 
out, that the mesh size of the textiles had an effect on hepatocytes’ aggregation behavior. 
On large meshes, the hepatocyte aggregation required 48 hours, whereas on smaller 
meshes it required four days. The pores of the textiles were filled with aggregates, which 
showed the possibility of immobilizing hepatocyte aggregates on periodical textile 
structures. 
In another study, Zong et al. (2005) investigated biodegradable nonwoven electrospun 
PLGA-based scaffolds for heart tissue constructs. The fiber diameters were 
approximately 1 μm, and the fibers were randomly oriented. The electrospun scaffolds 
were post-processed by uniaxial stretching in order to improve the fiber alignment. It was 
found out, that the oriented fiber structure promoted anisotropic cell growth along the 
stretching direction. 
Moreno et al. (2011) developed micro-fibrous nonwoven PET scaffolds for vascular 
grafting. Scaffolds with different fiber diameters and pore sizes were produced. The most 
suitable scaffold for culturing endothelial cells and smooth muscle cells was the one 
having the smallest diameter range (from 1 μm to 5 μm) and pore size range (from 1 μm 
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to 20 μm). The proposed reason was that the cells were more easily trapped in the smaller 
pores when seeding the cells. 
In addition, Ebersole et al. (2012) evaluated the suitability of electrospun nonwoven 
polycaprolactone (PCL) scaffolds for hernia repair. Six different scaffolds were produced 
by changing the polymer concentration and flow rate in electrospinning. The fibers were 
randomly oriented, and the fiber diameters ranged from 1.0 ± 0.1 μm to 1.5 ± 0.2 μm. 
Two of the six electrospun scaffolds (polymer concentration 12 %, flow rates 10 mL/h 
and 6 mL/h) were found to have appropriate mechanical properties for hernia repair. 
2.3.1 Polyethylene Terephthalate 
Polyethylene terephthalate (PET) belongs to the family of the engineering polyesters, and 
it is a basic material used in the textile industry. Polyester and PET are often used as 
synonyms, even though other polyesters (such as polybutylene terephthalate) exist, too. 
Because of its high crystallinity and hydrophobicity, PET is relatively stable in vivo, and 
it is considered to be a biostable material. (McKeen 2010, p. 100; Hu & Yang 2000; 
Ratner et al. 2013, p. 700; Ebnesajjad 2013, pp. 94–95) 
Polyesters contain characteristic ester groups in the polymer backbone and they are 
usually prepared by reacting a dibasic acid with a dihydric alcohol. The reaction is shown 
in Figure 2.5, where X and Y present aromatic or alkyl units. (Hu & Yang 2000) 
 
 
Figure 2.5. Reaction between a dibasic acid and a dihydric alcohol in polyester 
preparation, adapted from (Hu & Yang 2000). 
For polyethylene terephthalate, the X and the Y in the equation represent a 1,4-phenylene 
ring and ethylene, respectively. PET is formed in a polycondensation reaction between 
terephthalic acid and ethylene glycol, as shown in Figure 2.6. (Hu & Yang 2000) 
 
 
Figure 2.6. Polycondensation reaction between terephthalic acid and ethylene glycol, 
adapted from (Hu & Yang 2000). 
PET is a semicrystalline, thermoplastic polymer, which has excellent fiber forming 
properties due to its high crystallinity and melting point. The melting point and glass 
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transition temperature of PET are 265 °C and 65−105 °C, respectively. PET fiber has 
many outstanding properties, for example high elastic modulus and breaking tenacity, 
good heat setting properties, and good thermal and light resistance. PET fiber is also 
highly resistant to oxidation and reduction, it can withstand severe bleaching, it has good 
resistance against most of the common organic solvents and hydrocarbon oils, and it has 
low moisture regain. (Ebnesajjad 2013, pp. 94–95; Michler & Baltá-Calleja 2012, p. 270; 
Hu & Yang 2000) 
PET is used in a wide range of applications, including synthetic fibers, food and beverage 
containers, V-belts and conveyor belts. In the medical field, PET is used as sutures, 
wound dressings, and scaffolds, and it is an especially popular material used in prosthetic 
vascular grafts. For vascular applications, PET is usually manufactured in woven or 
knitted form. (Ebnesajjad 2013, pp. 94–95; Alagirusamy & Das 2010, p. 470; McKeen 
2010, p. 100; Hu & Yang 2000) 
2.3.2 Melt Spinning 
Fiber-based polymer scaffolds used in cell culturing are manufactured via methods that 
are familiar from the textile industry. Polymer fibers can be manufactured by a number 
of methods, one of which is called melt spinning. Melt spinning is probably the simplest 
way to produce fibers, since neither solvent addition nor removal is necessary. Thus, melt 
spinning is often used for polymers which are able to melt without thermal degradation. 
Also, the polymer has to be thermally stable over a range of temperatures so that the 
correct extrusion viscosity can be achieved. (Mather & Wardman 2011, p. 130; van 
Blitterswijk 2008, p. 426) 
PET fibers are typically produced via melt spinning process, where the polymer melt is 
forced through a mold called a spinneret. A spinneret contains tiny capillary holes and 
the diameter of a hole is usually 100−400 μm. The number of the spinneret holes vary 
depending on the application. (Hu & Yang 2000) In addition to a spinneret, a melt 
spinning machinery typically consists of an extruder, a metering pump and a filter pack 
(Mather & Wardman 2011, p. 130). Figure 2.7 shows a schematic illustration of the melt 
spinning process. 
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Figure 2.7. Typical melt spinning process (Mather & Wardman 2011, p. 131). First, the 
polymer granules are fed in the screw extruder via polymer feed hopper. The granules 
are melted and the extruder screw brings the molten and compressed polymer towards 
the metering pump. The metering pump ensures that the polymer melt flows 
continuously through the filter pack, which in turn prevents the solid impurities from 
getting in the spinneret. Spinneret contains tiny capillary holes, through which the 
polymer melt passes. The formed filaments are cooled in quench air and gathered into a 
multifilament yarn, which might be treated with a spin finish application. Finally, the 
yarn reaches the roller. 
In the melt spinning process, polymer granules are fed in the screw extruder via polymer 
feed hopper. The screw extruder contains heated chambers. The polymer granules are 
melted and the screw brings the molten and compressed polymer towards the metering 
pump, which ensures the continuous flow of the polymer melt through the filter pack and 
finally through the spinneret’s holes. The filter pack prevents the solid impurities from 
getting in the spinneret. After the polymer melt has passed through the spinneret, the fiber 
filaments are cooled in quench air and gathered into a multifilament yarn. The yarn might 
be treated with a spin finish application. Finally, the yarn reaches the roller. (Mather & 
Wardman 2011, p. 130) 
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The velocity at which the filaments come out from the spinneret is typically much lower 
than the take-up velocity at the roller. Therefore the filaments stretch, which improves 
the mechanical properties of the filaments due to the ordering of the polymer chain 
structure. To further improve the quality of the yarn, melt spinning process is usually 
followed by drawing (stretching). During drawing, the filaments are stretched, for 
example by factors of five to ten times or even more. (Mather & Wardman 2011, pp. 130–
131) 
2.3.3 Weaving 
Weaving is a conventional and basic textile technique which can also be used to fabricate 
tissue engineering scaffolds. Weaving enables the formation of textile structures with 
controllable properties, such as porosity, morphology, and strength. (Tamayol et al. 2013) 
Some microstructural and mechanical properties of textile scaffolds made by weaving 
were already given in Table 2.2. 
Two distinct sets of yarns are needed in the process of fabricating woven textiles. One of 
the sets is a cross-wise set (‘weft’) and the other is a length-wise set (‘warp’). The fabric 
is formed by interlacing the weft and the warp at 90º to each other. Weaving process is 
conducted by a machine called a ‘loom’ (Figure 2.8). (Akovali et al. 2012, p. 157) 
 
Figure 2.8. A weaving loom and its main parts, adapted from (Wulfhorst et al. 2006, p. 
134). 
The weaving system contains a series of frames that are called ‘harnesses’. Warp yarns 
are threaded into a loom through harnesses, which, during the weaving process, raise 
certain warp yarns above the others. This creates a space (‘shed’) between the raised and 
non-raised warp yarns, and the weft is carried through the shed by a ‘shuttle’, where the 
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weft is placed in. The harnesses are moved for each pass of the shuttle and a reed pushes 
the weft to its intended position. The movement of the harnesses determines the type of 
the weave pattern. (Akovali et al. 2012, p. 157) Figure 2.9 shows a few typical weave 
patterns. 
 
Figure 2.9. Typical weave patterns. From left to right: plain weave, twill weave and 
satin weave. Adapted from (Akovali et al. 2012, p. 163). 
Plain weave is formed by passing yarns alternatively over and under each other. Thus, 
there are maximum number of interlacing points. It is the simplest and least expensive 
weave to produce. Plain weave is similar in both sides of the textile. In a twill weave, the 
interlacing points of the weft and warp yarns are located so that they form a diagonal 
pattern. The interlacing points float by one to the right or left. In a satin weave, the 
interlacing points float by greater than one to the right or left, and it has the least 
interlacing points. (Akovali et al. 2012, pp. 161–163) 
2.4 Previous Studies 
The immaturity of hPSC-CMs is an issue which is delaying progress in the field of cardiac 
tissue engineering. hPSC-CMs are found to be able to undergo structural and functional 
maturation when transplanted into the working myocardium of model species (van Laake 
et al. 2007). The observation shows, that these cells are able to mature when placed in a 
suitable environment, and there have been many attempts to find suitable stimuli for the 
in vitro maturation of the cells. (Denning et al. 2015) Some strategies are visualized in 
Figure 2.10. 
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Figure 2.10. In vitro maturation strategies for hPSC-CMs, adapted from (Denning et 
al. 2015). The strategies include biophysical, biochemical, genetic and environmental 
inducers. Here, the concentration will be on topography (circled in red). 
As Figure 2.10 shows, the in vitro maturation strategies include biophysical, biochemical, 
genetic and environmental inducers to improve the maturation of hPSC-CMs. Here, the 
concentration will be on cell culture substrates’ topography. The amount of published 
studies aiming for improving the maturation of hiPSC-CMs using the topography strategy 
is quite limited. Rather than hiPSC-CMs, most of the studies investigating CMs’ 
maturation are utilizing either hESC-CMs (for example, Salick et al. (2014) and Zhang et 
al. (2013)) or murine CMs (for example, Wang et al. (2011) and McCain et al. (2014)). 
Next, previous studies using both hiPSC-CMs and topography strategy are described 
briefly. 
One of the strategies for studying the effect of substrate topography on hiPSC-CMs’ 
maturation is using fiber structures as culture substrates. A study used copolymer fiber 
matrices. Ring opening polymerization of monomeric ε-caprolactone with methoxy 
polyethylene glycol at selected molar ratios was used for the generation of the 
copolymers. The most suitable combination was found to be polyethylene glycol (PEG) 
+ polycaprolactone (PCL), the molar ratios being 4 % and 96 %, respectively. PEG is a 
biocompatible and hydrophilic polymer, whereas PCL is a biodegradable and 
hydrophobic polymer. The polymers were electrospun on glass coverslips to form fiber 
mesh scaffolds mimicking ECM’s structure. The fibers had the average diameter of 0.6 
μm. The study showed that, compared to other test substrates, the cells grown on 4%PEG-
96%PCL scaffolds exhibited more organized sarcomeres, increased contractility and 
higher expression of genes associated with cardiac maturation. (Chun et al. 2015) 
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In another study hiPSC-CMs were cultured on a highly aligned nanofiber cardiac patch. 
Two scanning electron microscope (SEM) images of hiPSC-CMs growing on the 
nanofibers are presented in Figure 2.11. The nanofibers were made of polylactide-co-
glycolide (PLGA) by electrospinning, and the average fiber diameter was 0.95 μm. The 
nanofibers were deposited onto a custom manufactured rotating wheel, and the scaffolds 
were approximately 50 μm thick. The cells grown on aligned nanofibers were compared 
to cells grown on flat surfaces. Both of these cell culture substrates were coated with 1 % 
gelatin before seeding the cells. The cells grown on nanofibers exhibited more adult-like 
shape by stretching and elongating along the orientation of the aligned fibers. Also, the 
cells grown on nanofibers had longer sarcomeres (≈1.68 μm) than the control cells 
cultured on flat culture plates (≈1.59 μm). Also, in contrast to the control cells, the cells 
grown on nanofibers assembled into well-organized myofibrils with clear aligned Z-discs, 
and they exhibited enhanced calcium cycling. (Khan et al. 2015) 
 
Figure 2.11. SEM images of hiPSC-CMs growing on aligned nanofibers, adapted from 
(Khan et al. 2015). The length of the scale bar is 100 μm on the left image and 50 μm on 
the right image. 
A study carried out by Han et al. (2016) investigated if the maturation of hiPSC-CMs 
could be improved by culturing the cells on aligned electrospun fibrous scaffolds made 
of PCL. In addition to aligned fibrous scaffolds, the cells were cultured on random fibrous 
scaffolds, and also on flat culture substrates as a control. All of these substrates were 
coated with Matrigel. SEM images of the aligned and random fibrous scaffolds are 
presented in Figure 2.12. The fibrous scaffolds were approximately 100 μm in thickness 
and the average fiber diameter was approximately 0.7 μm. The hiPSC-CMs cultured on 
aligned fibrous scaffolds became elongated and extended in the direction parallel to the 
fiber alignment, but the hiPSC-CMs cultured on random fibrous scaffolds remained 
circular and stayed together. The hiPSC-CMs grown on flat culture substrates formed 
randomly oriented large cellular bundles. These results showed that hiPSC-CMs 
anisotropic alignment was induced by aligned fibrous scaffolds. It was also found out, 
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that the cells grown on aligned fibrous scaffolds exhibited improved sarcomere 
organization and increased expression of cardiac genes. However, the calcium handling 
properties of the hiPSC-CMs grown on aligned fibrous scaffolds were not improved. The 
study suggested that using cell alignment inducing scaffolds, as a single method, has 
limited effect on enhancing the hiPSC-CMs’ maturation. 
 
Figure 2.12. SEM images of aligned (left) and random (right) fibrous scaffolds, adapted 
from (Han et al. 2016). The lengths of the scale bars are 10 μm in both images. 
Another strategy for studying the effect of substrate topography on hiPSC-CMs’ 
maturation is micropatterning. A study investigated the effect of microgrooved substrates 
on calcium cycling of hiPSC-CMs. The hiPSC-CMs grown on microgrooved substrates 
were compared to hiPSC-CMs grown on flat surfaces (Figure 2.13). (Rao et al. 2013) 
 
Figure 2.13. Immunofluorescence images of hiPSC-CMs grown on flat substrate (left) 
and microgrooved substrate, adapted from (Rao et al. 2013). The myofibrils are seen in 
red (α-actinin). The nuclei are seen in blue (DAPI). In the left image, the cells are 
irregularly shaped and have disorganized sarcomeres, whereas in the right image the 
cells are more rod-like in shape and the sarcomeres are more organized. The lengths of 
the scale bars are 20 μm in both images. 
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The cells were seeded onto fibronectin coated microgrooved culture substrates made of 
polydimethylsiloxane (PDMS), which is a biologically inert, non-toxic polymer. The 
grooves were 10 μm in width, 4 μm in depth, and the grooves were 10 μm apart. These 
dimensions were chosen due to a preliminary study made with neonatal rat ventricular 
myocytes (NRVM), which presented that grooves of this width modified the calcium 
cycling properties of CMs most effectively. (Rao et al. 2013) Also, according to 
Robertson et al. (2013), the width of an adult CM is approximately 10 μm. The control 
cells were cultured on unstructured PDMS membranes. The study concluded, that 
microgrooved culture substrates induced cellular alignment and more organized 
sarcomere structures in addition to improved calcium cycling (Rao et al. 2013). 
Another study utilizing micropatterning for improving the functional maturation of 
hiPSC-CMs was carried out by Ribeiro et al. (2015). The hiPSC-CMs were seeded on 
polyacrylamide gel patterned with 1 % gelatin lines. The gelatin lines were 20 μm in 
width and they were 20 μm apart. The hiPSC-CMs were seeded on these lines, and they 
were compared to human fetal CMs cultured on same kinds of substrates. The study 
showed that by adjusting the culture conditions the contraction stress of a single hiPSC-
CM could be increased to values higher than those of human fetal CMs. Also, the hiPSC-
CMs exhibited electrophysiological maturation, increased expression of cardiac genes, 
and improved sarcomere organization. 
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3. AIMS OF THE STUDY 
The aim of this study was to find out whether the structural maturation of hiPSC-CMs 
can be enhanced by growing them on woven PET textile structures. A visual comparison 
of hPSC-CMs and adult human CMs is shown in Figure 3.1. 
 
Figure 3.1. A visual morphology comparison between hPSC-CM and adult CM, 
adapted from (Robertson et al. 2013). 
When grown on a flat surface, for example on a Petri dish, hiPSC-CMs tend to become 
circular and irregularly shaped, whereas adult CMs are rod-like. Also, the sarcomere 
structures in hiPSC-CMs are disarrayed, unlike in adult CMs, where the sarcomeres are 
highly organized. In addition, adult CMs may have multiple nuclei, while hiPSC-CMs 
are mononucleated. 
The hypothesis is that hiPSC-CMs will become morphologically more mature when 
grown on textile structure. The textile topography is expected to guide the cell growth so 
that the hiPSC-CMs would become more rod-like in shape. Also, the growing along the 
fibers is expected to have a positive effect on the sarcomere structure organization. 
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4. MATERIALS AND METHODS 
4.1 Materials 
In this study, hiPSC-CMs were grown on five different PET textile structures. Textiles 
were labelled by consecutive numbering: PET1, PET2, PET3, PET4 and PET5. PET4 and 
PET5 were produced in Tampere University of Technology, and they were blue in color 
(Table 4.1). The yarn used for weaving the textiles was a PET multifilament yarn (Finn-
Nauha Oy, Haapamäki, Finland). The yarn was 78 dtex (g/10,000 m) in fineness and 20 
turns/meter in twist. Each yarn consisted of 24 filaments. The structure of PET4 was a 
plain weave, and the structure of PET5 was a plain weave derivate. (Stenlund 2013)  
Table 4.1. Textiles produced in Tampere University of Technology. The images were 
taken with a Zeiss Axio Vert.A1 microscope and AxioCam MRc5 camera; 5x objective 
was used. In the figures, the warp yarns are horizontal and the weft yarns are vertical. 
Name and 
details 
Structure Manufacturer 
PET4; 
blue, heat 
treated 
 
Yarn: Finn-Nauha Oy, 
Haapamäki, Finland 
Textile: Tampere 
University of 
Technology 
PET5; 
blue, heat 
treated 
 
Yarn: Finn-Nauha Oy, 
Haapamäki, Finland 
Textile: Tampere 
University of 
Technology 
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By contrast, PET1, PET2 and PET3 were commercial, colorless (transparent) textiles 
produced by Inka Oy (Killinkoski, Finland). The textile structures are presented in Table 
4.2. 
Table 4.2. Commercial textiles used in this study. The images were taken with a Zeiss 
Axio Vert.A1 microscope and AxioCam MRc5 camera; 5x objective was used. In the 
figures, the warp yarns are horizontal and the weft yarns are vertical. 
Name and 
details 
Structure Manufacturer 
PET1; 
colorless, 
heat 
treated, 
textured 
yarn 
 
Inka Oy, Killinkoski, 
Finland 
PET2; 
colorless, 
heat 
treated, 
textured 
weft yarn 
 
Inka Oy, Killinkoski, 
Finland 
PET3; 
colorless, 
heat 
treated, 
textured 
yarn 
 
Inka Oy, Killinkoski, 
Finland 
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There was not much information provided about the commercial textiles. In PET2, the 
weft yarn was a textured yarn. In PET1 and PET3, both warp and weft yarns were 
textured. All the textile samples (PET1–PET5) were heat treated in Tampere University 
of Technology in order to flatten the textiles so that the imaging of the samples would be 
easier. 
The fiber (filament) diameters were measured from immunostained images by using 
ImageJ software and utilizing the autofluorescence of the textiles, which was seen with 
Alexa Fluor 568 (red) and 488 (green). Autofluorescence makes the fibers visible, even 
though only the stained cell structures should be seen. This enabled the measurement of 
fiber diameters by using ImageJ’s line selection tool: a straight line was drawn from 
fiber’s edge to the other edge perpendicular to the longitudinal axis of the fiber, and the 
length of the drawn line was measured with the software. The measurements were done 
for multiple images of each textile and the average value was calculated. For each textile, 
10 measurements were used for calculating the average fiber diameter. The diameters 
were 20−25 μm for all the textiles, and the averages ± standard deviations are presented 
in Table 4.3. 
Table 4.3. Average fiber diameters ± standard deviations. 
Sample Average fiber diameter (μm) 
PET1 24.4 ± 1.82 
PET2 23.2 ± 1.43 
PET3 22.9 ± 1.91 
PET4 20.4 ± 1.53 
PET5 22.0 ± 1.42 
 
Control samples were generated by plating hiPSC-CMs on glass coverslips (13 mm in 
diameter) instead of PET textiles. The cell line used in this study was a control cell line 
UTA04602.WT produced from a healthy individual. The textiles and coverslips were 
coated with 0.1 % gelatin passively at room temperature for one hour. A table of used 
reagents and their suppliers and/or manufacturers which will not be mentioned in Chapter 
4 is provided in Appendix D. 
4.2 Workflow 
The workflow of the study is illustrated in Figure 4.1. The first step was to differentiate 
hiPSCs to CMs (Subchapter 4.3), which took two weeks. In the next step, dissociation, 
beating CM aggregates were collected and single cells were plated on PET textiles 
(Subchapter 4.4). After the culturing period, the analyzing of samples started on day 27. 
On day 27, samples were analyzed with live/dead imaging (Subchapter 4.5), and the 
immunostaining protocol (Subchapter 4.6; Appendix B) was started by fixing the cells. 
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The immunostaining protocol was continued on day 28 and finished on day 29, after 
which the samples were imaged with a fluorescence microscope. 
 
Figure 4.1. The workflow of the study. 
In total, the workflow was carried out five times. The steps of the workflow are explained 
in the following subchapters in further detail. The sarcomere orientation and length were 
analyzed from the immunostained images with a software called CytoSpectre (Subchapter 
4.7), which allows the automatic quantification of these structural properties in 
microscopy images (Kartasalo et al. 2015). Also, the method for evaluating statistical 
significance is presented in Subchapter 4.8. 
4.3 Cardiomyocyte Differentiation 
The cell line used in this study (UTA04602.WT) was generated from dermal fibroblasts 
of a healthy 55-year-old female by Heart Group of BioMediTech, Tampere. In this study, 
the laboratory work started from the cardiomyocyte differentiation. The differentiation of 
hiPSCs to cardiomyocytes was carried out by using mouse endodermal-like (END-2) cell 
Day 1:
Cardiomyocyte 
differentiation
Day 6:
Medium change (0% 
KO-SR hES)
Day 8:
Medium change (0% 
KO-SR hES)
Day 13:
Medium change (0% 
KO-SR hES)
Day 15:
Medium change (10% 
KO-SR hES)
Day 17:
Dissociation, plating 
of hiPSC-CMs on PET
Day 20:
Medium change (EB 
medium)
Day 24:
Medium change (EB 
medium)
Day 27:
Live/dead imaging, 
fixing of hiPSC-CMs
Day 28:
Double fluorescence 
protocol started
Day 29:
Double fluorescence 
protocol finished
Day 30:
Imaging of 
immunostained 
hiPSC-CMs
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co-culture protocol. hiPSC colonies were plated on END-2 cells which give 
cardiomyocyte differentiation promoting substances to the medium (Mummery et al. 
2003; Passier et al. 2005). 
Mitomycin C treated END-2 cells were plated on 12-well plates a day before 
differentiation. The next day the plated END-2 cells were visually evaluated, after which 
the differentiation protocol could be started. The first step was to change 0 % KO-SR hES 
medium supplemented with 2.29 mg/ml ascorbic acid (Table 4.4) to the END-2 cells 
containing well plates about an hour before plating the iPSC colonies. The quantity of 
ascorbic acid added was 0.7 ml of 50 mg/ml stock solution to 12 ml of medium. 
Table 4.4. Contents of 0 % KO-SR hES medium. 
Volume Ingredient Quantity 
48.75 ml KO-DMEM  
0.5 ml NEAA 1 % 
0.5 ml GlutaMax 2 mM 
0.25 ml Pen/Strep. 50 U/ml 
97.5 µl β-mercaptoethanol 0.1 mM 
(2.8 ml Ascorbic Acid (added just 
before use)) 
3.0 mM 
 
The next step was to separate the mouse embryonic fibroblast (MEF) feeder layer from 
the 6-well plates containing the hiPSC colonies. This was done by pipetting. The 
procedure had to be gentle enough so that as small amount of iPSC colonies as possible 
was removed with MEF layer. When the MEF layer was detached from the well plate and 
the iPSC colonies, the pieces of MEF layer were swirled to the center and removed. 
Next, the hiPSC colonies were scraped to the culture medium as whole as possible. The 
colonies were swirled to the center of the well, from where the colonies were aspirated 
with a pipette and plated on the END-2 cells. hiPSC colonies from one well were dealt 
into four END-2 wells. After plating the colonies, the well plates were manually shaken 
a bit in order to spread the colonies evenly across the wells. The plates were stored in 37 
°C incubator. On days 6, 8, and 13 0 % KO-SR hES medium was changed to the cells. 
On day 15, the medium was changed to 10 % KO-SR hES medium (Table 4.5). 
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Table 4.5. Contents of 10 % KO-SR hES medium. 
Volume Ingredient Quantity 
43.75 ml KO-DMEM  
5 ml KO-SR 10 % 
0.5 ml NEAA 1 % 
0.5 ml Glutamax 2 mM 
0.25 ml Pen/Strep. 50 U/ml 
97.5 µl β-mercaptoethanol 0.1 mM 
 
After day 15 the media were changed three times a week. The first beating aggregates 
usually appeared between days 8 and 14. Most of the beating aggregates appeared before 
day 21 but new beating areas could still appear until day 30. In this study, the dissociation 
of beating aggregates was carried out on day 17. 
4.4 Dissociation of Beating Aggregates 
On day 17, the beating aggregates were isolated from 12-well plates with a microscalpel 
and collected into culture medium. When enough areas were collected (one beating 
aggregate per sample for imaging, two beating aggregates for RNA extraction), the 10 % 
KO-SR hES medium was removed and the excised tissue was washed in Low-Ca (Table 
1, Appendix A) for 30 minutes at room temperature. Then, buffer 1 was removed and 
replaced with Enzyme medium (Table 2, Appendix A), in which the areas were incubated 
for 45 minutes at 37 °C. During the time of incubation, both PET textiles and coverslips 
were disinfected with 70% ethanol and dried.  
After the incubation, buffer 2 was removed and replaced with a KB medium (Table 3, 
Appendix A), in which the beating areas were washed for an hour at room temperature. 
The PET textiles and coverslips were coated with 0.1 % gelatin during that time. Then, 
buffer 3 was replaced with EB medium (Table 4.6), where the aggregates were broken 
down by pressing pipette’s tip against the well plate’s bottom and pipetting the solution 
up and down several times. 
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Table 4.6. Contents of EB medium (20% FBS KO-DMEM). 
Volume Ingredient Quantity 
38.75 ml KO-DMEM  
10 ml FBS 10 % 
0.5 ml NEAA 1 % 
0.5 ml Glutamax 2 mM 
0.25 ml Pen/Strep. 50 U/ml 
 
After that, 50 μl of cell suspension was plated on every PET textile and coverslip. The 
samples were incubated for 45 minutes at 37 °C after which 650 μl of warm EB medium 
was pipetted into every well. Textile samples in EB medium on a 24-well plate are shown 
in Figure 4.2.  
 
Figure 4.2. PET textile samples in EB medium on a 24-well plate. 
The media were changed on days 20 and 24. The analyzing of samples started on day 27. 
Analyzing methods included live/dead imaging, immunocytochemistry and fluorescent 
microscopy. 
4.5 Live/Dead Imaging 
Live/dead imaging was done on day 27. hiPSC-CMs were stained with a live/dead 
staining kit (L3224 LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells, 
Molecular Probes, Inc, Invitrogen). The kit included two fluorescent dyes: 1 mM Calcein 
AM (C-AM), which stains live cells in green (wavelength 488), and 2 mM Ethidium 
homodimer-1 (EtHD-1), which stains dead cells in red (wavelength 568). C-AM and 
EtHD-1 were thawed, spun down in centrifuge, and pipetted in warm EB medium (37 
°C). The amounts of C-AM and EtHD-1 pipetted into 10 ml of EB medium were 2 μl and 
5 μl, respectively. 
500 µl of live/dead stain solution was prepared for each sample. The samples were 
incubated for 30 minutes in 37 °C before starting the imaging. Live/dead imaging was 
performed using an Olympus BX61WI water immersion fluorescence microscope and 
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Hamamatsu ORCA-ER (Model C4742-80-12AG) camera. The samples were imaged in 
EB medium on a Petri dish using 10x and 40x objectives. 
4.6 Immunocytochemistry and Fluorescent Microscopy 
The hiPSC-CMs were stained using a double-fluorescence protocol (Appendix B). The 
protocol was started by fixing the cells on day 27, continued on day 28 and finished on 
day 29. Primary antibodies used were goat cardiac troponin T (ab64623, Abcam) and 
mouse myosin-binding protein C (MYBPC) (sc-166081, Santa Cruz). Secondary 
antibodies used were Alexa Fluor 568 donkey anti-goat (Life Technologies) and Alexa 
Fluor 488 donkey anti-mouse (Life Technologies). The localization of stained sarcomere 
proteins, myosin-binding protein C and troponin T, are shown in Figure 4.3. 
 
Figure 4.3. Localization of studied cardiomyocyte sarcomere proteins, adapted from 
(Maron & Maron 2013). 
After the double-fluorescence protocol was carried out, the samples were mounted on 
microscope slides (Menzel-Gläser, Thermo Scientific) with a Vectashield Mounting 
Media with DAPI (H-1200, Vector Lab), which stains the nuclei of the cells. The samples 
were imaged on day 30 with a Zeiss Imager.M2 Axio fluorescence microscope with 
ApoTome and AxioCam MRm camera. Z-stack images were taken with a 40x oil 
immersion objective. The images were processed with ImageJ software. 
4.7 Analysis of Sarcomere Orientation and Length 
The sarcomere orientation and length were analyzed from the immunostained images 
with a software called CytoSpectre, which allows the automatic quantification of these 
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structural properties in microscopy images (Kartasalo et al. 2015). Before using the 
software, the images were rotated so that the fibers of the textiles were oriented in the 
same direction lengthwise. All the fibers, which had hiPSC-CMs growing on top of them, 
were set vertically, as illustrated in Figure 4.4. The direction parallel to the longitudinal 
axis was set to be 90°. By rotating the images, the sarcomere orientations of different cells 
relative to the longitudinal axis of the fibers could be compared with each other. The 
rotating of the images of hiPSC-CMs grown on coverslips was not necessary, since the 
cell culture substrate was flat and had no longitudinal direction. 
 
Figure 4.4. The images were rotated so that the sarcomere orientations of hiPSC-CMs 
grown on PET textiles could be analyzed as one group, and then be compared to the 
hiPSC-CMs grown on coverslips. The direction parallel to the longitudinal axis was set 
to be 90°. 
Only the images of hiPSC-CMs with clearly showing sarcomeres were included in the 
analysis. If the signal-to-noise ratio was lower than one, the image was excluded from the 
analysis. The following properties were analyzed with the software: mean sarcomere 
orientation, mean sarcomere length, sarcomere length standard deviation, circular 
variance, and angular standard deviation. 
Circular variance and angular standard deviation are measures for the spread of the 
orientation distribution. Circular variance can get values from 0 to 1. If all the sarcomeres 
were aligned along a single orientation, the circular variance would have a value close to 
zero. By contrast, if the sarcomere orientations were evenly distributed around the half 
circle (0°–180°), the circular variance would have a value close to one. Angular standard 
deviation can get values from 0 to √2 ≈ 1,41. Similarly to circular variance, angular 
standard deviation is low when the sarcomeres are aligned along a single orientation, and 
high when the orientations are evenly spread out around the half circle. (Kartasalo et al. 
2015) 
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4.8 Statistical Analysis 
Differences between hiPSC-CMs grown on PET textiles and coverslips were assessed by 
Student’s t-test. The test used was an independent two-sample test assuming unequal 
variances. The p-values were calculated using Microsoft Excel and the values from two-
tailed tests were used. The threshold for significant difference was p < 0.05. 
The statistical significance was calculated for circular variance and angular standard 
deviation (measures for the spread of the sarcomere orientation distribution). Also, it was 
calculated for mean sarcomere length and sarcomere length standard deviation.  
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5. RESULTS 
5.1 Imaging and Cell Shape 
The structural maturation of hiPSC-CMs grown on PET textiles was evaluated by 
observing their structural properties and comparing them to those of hiPSC-CMs cultured 
on coverslips. The compared structural properties were morphology of the cells, 
sarcomere organization and orientation, and the length of sarcomeres. Also, the 
multinucleation of the cells was studied. 
The cells were imaged with different kinds of microscopes. The morphology of cells 
grown on coverslips was observable with brightfield microscopy, whereas the cells grown 
on PET textiles were very difficult to detect without staining them and using a 
fluorescence microscope. Figure 5.1 illustrates the problem. 
 
Figure 5.1. hiPSC-CMs were difficult to detect from the textiles without staining the 
cells. The arrows point to “bumps”, which lie on the fibers and might be nuclei. The 
image was taken with Nikon TiE FN1 microscope and Hamamatsu ORCA-Flash 4.0 V2 
camera. 
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The “bump”, to which the arrow points in Figure 5.1, could be a nucleus, but it also might 
just be a lump of gelatin coating, impurity, etc. The cell structure is not visible in the 
image. In order to make the cells recognizable, the hiPSC-CMs grown on PET textiles 
had to be stained. Both live/dead staining and immunocytochemistry were used. Figure 
5.2 shows a similar bump as seen in Figure 5.1, but the cell is immunostained with the 
double-fluorescence protocol. 
 
Figure 5.2. hiPSC-CM on PET4 textile. In the image, nucleus is seen in blue (DAPI), 
MYBPC is seen in green, and troponin T is seen in red. Also, there is some degree of 
autofluorescence, which makes the fiber structure show as well. 
In Figure 5.2, the bump is clearly a nucleus, since it has been stained with DAPI (blue). 
In the image, the autofluorescence of PET textile makes it possible to see the fiber 
structure of the textile as well. PET4 and PET5, which were blue in color, showed the 
most autofluorescence, but autofluorescence occurred also with colorless textiles (PET1, 
PET2 and PET3). 
Autofluorescence made the live/dead imaging challenging, and the method was found to 
be rather poor for imaging hiPSC-CMs grown on textiles, as can be seen in Figure 5.4 
and Figure 5.5. Some of the most representable images taken of live cells are presented 
in Figure 5.3. The live/dead colors stained the whole cell. 
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Figure 5.3. Images of live cells, cells stained with live/dead stainings. The length of the 
scale bar is 20 μm. 
In Figure 5.3, the cells can be recognized quite well. However, sometimes it seemed like 
the cells had migrated between the fibers and inside the textile structure. In these cases, 
the fluorescent dye was “glowing” from under the fibers, as seen in Figure 5.4. 
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Figure 5.4. Unclear images of live/dead stained samples. The length of the scale bar is 
20 μm. 
As seen in Figure 5.4, it is not clear whether the fluorescent dye has been absorbed by the 
textile or whether there are cells involved. In the image on the left, the intensity of the 
fluorescent dye is highest in the gap between two fibers (indicated with an arrow), which 
could mean that there is a cell under the uppermost fibers. There is also a lot of 
autofluorescence in the fiber surfaces. In the image on the right, there is not so much 
autofluorescence, but the fluorescent dye glows from under a single fiber. This could 
mean, that a cell is growing on the bottom side of that fiber, but the cell cannot be properly 
seen. Two more unclear images are presented in Figure 5.5. 
 
Figure 5.5. Unclear live/dead images. The length of the scale bar is 50 μm. 
In Figure 5.5, it is be possible that there are cells growing under the fibers as indicated 
with the white arrows. The situations shown in Figure 5.4 and Figure 5.5 were very 
common when live/dead imaging was performed. Therefore, live/dead imaging did not 
give clear results about hiPSC-CMs maturation. Also, only a small amount of cells was 
found, so it was not reasonable to make comparisons between the cells grown on different 
textile structures. Instead, the hiPSC-CMs grown on PET textiles were treated as one 
group in the analysis. 
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The best method used in this study for evaluating the structural maturation of hiPSC-CMs 
was immunocytochemistry and imaging of the immunostained samples. Immunostaining 
revealed the cell structure, sarcomeres and nucleus. Even though the amount of cells 
detected from immunostained samples was very small, it could be seen that the cells did 
grow along the PET fibers and their shape became more rod-like. Images of 
immunostained samples on the different PET textiles are presented in Figure 5.6. 
 
Figure 5.6. Images of immunostained samples. In the image, nucleus is seen in blue 
(DAPI), MYBPC is seen in green, and troponin T is seen in red. The length of the scale 
bar is 50 μm. On PET1, the morphology of the cell is different compared to the cells 
grown on PET2–PET5. This is only because the cell happened to be growing on an 
interlacing point of the textile. Usually, the cells did not cross interlacing points. 
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As seen in Figure 5.6, the hiPSC-CMs grown on PET textiles exhibit more adult-like 
shape than the control cell. Even though the sarcomeres (green) are not well developed in 
cells grown on PET1 and PET4 in Figure 5.6, it was not a pattern seen in all the cells 
grown on these particular textiles. Also, the cells did not favor any textile structure over 
the others, even though in Figure 5.6 the sarcomeres are more developed in cells grown 
on PET2, PET3 and PET5. All in all, there was a variety of more and less matured cells 
on all the textile structures. 
5.2 Sarcomere Orientation and Length 
The sarcomere orientation and length were analyzed with the CytoSpectre software. As a 
CM matures, its shape changes from circular to rod-like. Along with this transition, the 
sarcomeres grow in length and align with the longitudinal axis of the CM. (Rodriguez et 
al. 2014) In this study, it was observed that the hiPSC-CMs were able to grow along the 
fibers of the PET textiles and become more rod-like in shape. Thus, the hypothesis was, 
that the mean sarcomere orientation for the cells grown on textiles would be 90°, which 
is the direction parallel to the longitudinal axis of the fibers. In contrary, the irregularly 
shaped control cells grown on coverslips had no clear longitudinal direction. 
The analysis was performed for 38 hiPSC-CMs grown on PET textiles, and for 35 control 
hiPSC-CMs grown on coverslips. However, for the cells grown on textiles, only 27 cells 
remained to analyze, because the signal-to-noise ratio was too low for the rest of the cells. 
Due to the small amount of cells found on the textiles, the cells grown on different textile 
structures were not analyzed separately but as one group. The averages of the applicable 
results from the CytoSpectre analysis are presented in Table 5.1. More detailed results 
are presented in Appendix C. 
Table 5.1. Results from the CytoSpectre analysis. The values are presented as averages. 
More detailed results can be found in Appendix C. 
Result PET Control 
Mean sarcomere orientation 101.87° 48.41° 
Circular variance 0.15 0.40 
Angular standard deviation 0.51 0.84 
Mean sarcomere length 1.91 µm 1.89 µm 
Sarcomere length standard deviation 0.23 µm 0.30 µm 
 
Firstly, Table 5.1 shows the mean orientation for cells grown on coverslips and PET 
textiles. The mean orientation analysis for control cells was not very reasonable since the 
cells were round and also the sarcomeres were often coiled, as illustrated in Figure 5.7. 
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Figure 5.7. Control hiPSC-CMs grown on coverslips. The length of the scale bar is 50 
μm. The cells are circular, and the sarcomere structures are not well organized. 
By contrast, the cells grown on PET textiles showed a rather uniform sarcomere 
orientation. The hypothesis was that the orientation of the sarcomeres would be 90°, and 
the average mean orientation was approximately 102°, which is quite close to the 
hypothesis. Also, two measures for the spread of the orientation distribution are included 
in Table 5.1: circular variance and angular standard deviation. Indicated by Student’s t-
test, there was a significant difference in both circular variance (p = 7.74 × 10–6) and 
angular standard deviation (p = 2.82 × 10–6) when comparing the cells grown on textiles 
to the cells grown on coverslips. Both of these measures were significantly higher for the 
hiPSC-CMs cultured on coverslips – for the hiPSC-CMs cultured on PET textiles the 
values were quite low. The mean orientation distributions of the hiPSC-CMs grown on 
coverslips (left) and PET textiles (right) are illustrated as rose diagrams in Figure 5.8. 
 
Figure 5.8. Sarcomere mean orientation distribution of control cells grown on 
coverslips (left) and cells grown on PET textiles (right). The numbers from the center of 
circle to the circular arc represent the frequency of the orientations fallen within the 
sectors – the scales in these two diagrams differ from each other. 
As seen in Figure 5.8, the sarcomere orientations are clearly more uniform for the cells 
grown on PET textiles. This also correlates with the result, that the sarcomere orientations 
of the cells grown on textiles got lower circular variance and angular standard deviation 
values. Also, most of the mean orientations are near to 90° for the cells grown on textiles, 
which was the orientation parallel to the longitudinal axis of the fibers. 
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The other analyzed property was the sarcomere length. The reference values for immature 
hiPSC-CM and adult CM were found in the literature (Yang et al. 2014), and they were 
1.6 μm and 2.2 μm, respectively. As seen in Table 5.1, the average sarcomere lengths for 
cells grown on PET textiles and cells grown on coverslips were 1.91 μm and 1.89 μm, 
respectively. The values were very close to each other, but the average sarcomere length 
was slightly longer for the cells grown on textiles. However, as indicated by the Student’s 
t-test, the difference was not statistically significant (p = 0.64). For the cells grown on 
PET textiles, the mean sarcomere lengths varied from 1.60 μm to 2.48 μm (Figure 5.9), 
and for the cells grown on coverslips, the lengths varied from 1.68 μm to 2.13 μm (Figure 
5.10). 
 
Figure 5.9. Analyzed mean sarcomere lengths for 27 hiPSC-CMs grown on PET (blue 
bars), and reference values (white bars) given in (Yang et al. 2014). The lengths were 
organized from the shortest to the longest. The error bars represent the sarcomere 
length standard deviations. 
Figure 5.9 shows the mean sarcomere lengths for all the analyzed hiPSC-CMs grown on 
PET textiles (27 cells). Almost all the mean sarcomere lengths of cells grown on PET 
textiles (blue bars) fall in between the literature values (white bars): one value was higher 
than the literature value for adult cardiomyocytes. Figure 5.10 represents a similar chart 
for the hiPSC-CMs grown on coverslips. 
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Figure 5.10. Analyzed mean sarcomere lengths for 35 hiPSC-CMs grown on coverslips 
(blue bars), and reference values (white bars) given in (Yang et al. 2014). The lengths 
were organized from the shortest to the longest. The error bars represent the sarcomere 
length standard deviations. 
As seen in Figure 5.10, all the sarcomere lengths of hiPSC-CMs grown on coverslips 
(blue bars) fall in between the literature values (white bars). Both in Figure 5.9 and in 
Figure 5.10 the sarcomere lengths are quite evenly distributed between the lowest and 
highest values.  
In the previous two figures, the error bars represent the sarcomere length standard 
deviations. As seen in Table 5.1, the average sarcomere length standard deviation for cells 
grown on PET textiles and cells grown on coverslips were 0.23 μm and 0.30 μm, 
respectively. The standard deviation of sarcomere lengths was significantly higher (p = 
0.0023) for the cells grown on coverslips, which means the cells grown on PET textiles 
exhibited more uniform sarcomere lengths. 
5.3 Multinucleation 
In addition to other structural factors associated with CM maturation (shape, sarcomere 
orientation, and sarcomere length), also the multinucleation of the cells was studied. 
Binucleated hiPSC-CMs were found on PET textiles, and a few of them are shown in 
Figure 5.11. Binucleated cells were also found on coverslips. 
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Figure 5.11. Binucleated hiPSC-CMs on PET textiles. The length of the scale bar is 50 
μm. The nuclei are shown in blue (DAPI). 
In Figure 5.11, the nuclei are shown in blue color (DAPI). According to Rodriguez et al. 
(2014), at the same time as the structural maturation of hiPSC-CMs is occurring, also the 
percentage of multinucleated cells increases. In this study, approximately 30 % (38 cells 
analyzed) of hiPSC-CMs grown on PET were binucleated, whereas the percentage for 
hiPSC-CMs grown on coverslips was approximately 17 % (35 cells analyzed).  
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6. DISCUSSION 
6.1 Maturation of hiPSC-CMs 
In this study, the maturation of hiPSC-CMs was evaluated by studying the cells’ structural 
features: shape, sarcomere orientation, sarcomere length, and multinucleation. It was 
observed, that the hiPSC-CMs grown on PET textiles received topographical cues from 
the textile structure: the cells grew along the fibers, which made the cells rod-like in 
shape. In contrary, the hiPSC-CMs grown on coverslips did not receive the same kinds 
of topographical cues, and they became circular or irregularly shaped.  
It has been shown, that the shape of CMs regulate the sarcomere alignment (Bray et al. 
2008). For the cells grown in PET textiles, the sarcomeres aligned with the longitudinal 
axis of the PET fibers. Because the cells grew along the PET fibers, this also meant, that 
the sarcomeres aligned with the longitudinal axis of the cells. In Figure 6.1, this kind of 
sarcomere alignment is seen within an immunostained sample. The sarcomeres of control 
cells were not as well organized. The differences in sarcomere orientation will be 
discussed next. 
 
Figure 6.1. Sarcomere alignment within hiPSC-CMs cultured on PET textile. The 
sarcomeres are shown in green (MYPBC). The localization of Z-discs and M-lines are 
also observable. 
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The results concerning the sarcomere orientations of the hiPSC-CMs grown on textiles 
were as expected. The hypothesis was, that the sarcomeres would align parallel to the 
longitudinal axis of the PET fibers (or cells), which in this case meant the mean 
orientation should be 90°. The results showed, that the average mean sarcomere 
orientation for the cells grown on PET textiles was approximately 102°, which is close to 
the hypothesis. For the cells grown on coverslips the mean orientation analysis was not 
very reasonable since the cells were round and also the sarcomeres were often coiled. 
However, the sarcomere orientations of hiPSC-CMs grown on textiles and coverslips 
could be compared by utilizing measures that describe the spread of the orientation 
distribution: circular variance and angular standard deviation. Circular variance can get 
values from 0 to 1, and angular standard deviation from 0 to √2. The values of circular 
variance and angular standard deviation are low when the sarcomeres are aligned along a 
single orientation, and high when the orientations are evenly spread out around the half 
circle (0°–180°). The circular variances for cells grown on PET textiles and cells grown 
on coverslips were 0.15 and 0.40, respectively. In the same order, the angular standard 
deviations were 0.51 and 0.84. Both of these were significantly lower for the cells grown 
on textiles, which means that the sarcomeres were more uniformly oriented. Based on 
these results, it can be concluded, that culturing the hiPSC-CMs on textiles had a desired 
effect on the sarcomere orientation. In addition to structural maturation, the sarcomere 
organization is related to the functional maturation of hiPSC-CMs. In a study carried out 
by Feinberg et al (2012) demonstrated, that improved sarcomeric organization resulted in 
increased action potential duration, contractile stress and Ca2+ transient kinetics, which is 
consistent with functional maturation. 
In the case of sarcomere lengths, there was no significant difference between the cells 
grown on PET textiles (on average 1.91 μm) and the cells grown on coverslips (on average 
1.89 μm). The value was surprisingly good for the control cells, because the literature 
values for immature hiPSC-CMs and adult CMs were 1.6 μm and 2.2 μm, respectively 
(Yang et al. 2014). Because the cells grown on coverslips were more immature in shape 
and the sarcomere orientation was significantly less uniform compared to the cells grown 
on PET textiles, also the lengths of the sarcomeres were expected to be shorter. Instead, 
both the cells grown on textiles and the cells grown on coverslips exhibited average 
sarcomere lengths longer to the ones seen in fetal CMs, which is 1.8 μm (Feric & Radisic 
2016). In a study carried out by Lundy et al. (2013), hiPSC-CMs’ sarcomere lengths 
increased to that of fetal CMs by using a long-term culture (80–120 days of in vitro 
differentiation and culture). The cells were grown on coverslips. In this study, the 
cardiomyocyte differentiation and the culturing of cells on textiles and coverslips took 
only 27 days, but still the average sarcomere lengths were longer. An explanation for the 
surprisingly long sarcomeres of the cells grown on coverslips could be that, when coiled 
(as in Figure 5.7), the sarcomeres become longer on the outer edge than on the inner edge 
of the circle. This can skew the results. 
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Not all the sarcomeres were equal in length. For the cells grown on PET textiles, the 
sarcomere lengths varied from 1.60 μm to 2.48 μm, and for the cells grown on coverslips, 
the lengths varied from 1.68 μm to 2.13 μm. The maximum sarcomere length is 
approximately 2.2–2.3 μm, according to various sources (Klabunde 2015; Yang et al. 
2014; Kentish et al. 1986; Allen & Kurihara 1982), but the highest mean sarcomere length 
for hiPSC-CMs cultured on PET textiles was 2.48 μm. This might be an error in the 
analysis method. The sarcomere lengths were quite evenly distributed between the lowest 
and the highest values. It seems that, based on the sarcomere lengths, some of the hiPSC-
CMs were more mature than others. From the 35 control cells analyzed with CytoSpectre, 
approximately 77 % of the cells exhibited sarcomere lengths equal or longer to that of 
fetal CMs. For the cells grown on PET textiles (27 cells were analyzed), the percentage 
was approximately 63 %. According to Feric & Radisic (2016) the average sarcomere 
length in a relaxed adult CM is 2.0–2.2 μm. The percentages of control cells and cells 
grown on PET textiles that exhibited sarcomere lengths longer than 2.0 μm were 23 % 
and 26 %, respectively. It seems that, even though there was a higher amount of cells that 
exhibited mean sarcomere lengths typical to immature CMs (1.60–1.79 μm) among the 
cells grown on textiles than among the control cells, the amount of cells exhibiting 
sarcomere lengths typical to those of adult CMs was higher for the cells grown on textiles. 
The multinucleation of hiPSC-CMs was also studied, even though it is not clear whether 
the multinucleation of CMs is a maturation marker or not, and the studies regarding this 
matter are not unanimous. Some claim that hiPSC-CMs are mononucleated whereas most 
adult CMs are multinucleated (Robertson et al. 2013); some claim that approximately 25 
% of adult CMs are multinucleated (Yang et al. 2014); and some claim that fully 
differentiated CMs only have one nucleus (Sparrow & Schöck 2009). In this study, 
approximately 30 % of hiPSC-CMs grown on PET were binucleated, whereas the 
percentage for hiPSC-CMs grown on coverslips was approximately 17 %. Based on these 
results, it can be argued that growing hiPSC-CMs on PET textiles induces 
multinucleation. Depending on literature reference, the conclusion could be either desired 
or undesired. However, taking into consideration the other factors associated with 
structural maturation of CMs (shape and sarcomere orientation), it is reasonable to argue 
that cells grown on PET textiles were more mature than the control cells. 
6.2 Cell Culture Substrates 
Synthetic biomaterials are an attractive option for the production of cell culture substrates, 
because their properties, including topography and structure, can be tailored for the 
application. The most frequently used synthetic polymers in the field of cardiac tissue 
engineering are polyurethane (PU), polylactic acid (PLA), polycaprolactone (PCL), 
polyglycolic acid (PGA), and their copolymers. (Mathur et al. 2016) All these polymers 
are (or can be modified to be) biodegradable (Nair & Laurencin 2007). However, the 
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polymer used in the present study, PET, is not biodegradable but biostable (Ebnesajjad 
2013, pp. 94–95) 
In tissue engineering it is often desired that the scaffold is biodegradable, because that 
way the implant introduced to the body in the site of damaged tissue is slowly replaced 
by regenerated tissue (Nair & Laurencin 2007). Cardiac tissue engineering aims to repair 
damaged heart tissue, so biodegradable textiles could also be investigated for the studies 
of improving the maturation of the hiPSC-CMs. The material choice depends on the 
application and is not always unambiguous: for example, biodegradable PU patches have 
been investigated for mechanical supports after myocardial infarction, but it is unclear 
how long the material should remain in place (Hashizume et al. 2013). The biodegradation 
times alter from polymer to polymer. For example, PGA loses its strength in 1–2 months 
and mass in 6–12 months, whereas high molecular weight poly-L-lactic acid (PLLA) 
loses its strength in 6 months and the total resorption in vivo takes 2–5.6 years. The 
degradation rate for PCL is 2–3 years. (Nair & Laurencin 2007) 
Also, in tissue engineering, the usual goal is to mimic the mechanical (and other) 
properties of the native tissue with a biomaterial (van Blitterswijk 2008, pp. 404–405). 
The Young’s modulus of human cardiac muscle is approximately 80 kPa (Herman 2007, 
p. 214). That is very low compared to the moduli of many biodegradable polymers (for 
example, 7.0 GPa for PGA; 2.7 GPa for PLLA; and 0.4 GPa for PCL) (Gunatillake & 
Adhikari 2003). The Young’s Modulus of PET is 2.76–4.14 GPa (Callister & Retwisch 
2011, p. A9). Also, in the case of textiles, the fibers need to have sufficient strength in 
order to make the manufacturing of the fabric possible with a weaving loom etc. In order 
to mimic the mechanical properties of the heart with a textile structure, the textile could 
be coated with a soft coating thick enough to cover some of the mechanical cues coming 
from the textile to the cells, but also thin enough to preserve the topographical cues. 
Hydrogels are a good option for a coating, because their Young’s modulus is usually on 
the order of kiloPascals (Oyen 2014). 
PET is a simple, common material, and it was readily available for the present study. PET 
has been used in cardiac applications before, but, to the writer’s knowledge, not for 
improving the maturation of hiPSC-CMs. In previous studies (Khan et al. 2015; Han et 
al. 2016; Chun et al. 2015), scaffolds made of aligned or random electrospun nanofibers 
seemed to be popular, but in the present study, woven textiles were used. Also, the fibers 
used for making the woven textiles were manufactured by melt spinning process. The 
fiber diameters used in the previous studies utilizing aligned nanofibers (Khan et al. 2015; 
Han et al. 2016) varied from 0.7 μm to 0.95 μm. These fiber diameters were very small 
compared to the fiber diameters of the PET textiles used in this study (20−25 μm). Also, 
the diameters of the nanofibers were very small compared to the width of adult CMs (10 
μm) (Robertson et al. 2013). However, the strategy in these previous studies was a bit 
different compared to the present study, because the aim was not to grow the cells on top 
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of single fibers but on top of many aligned fibers guiding the cells’ direction of growth 
along the fiber orientation (illustrated in Figure 2.11, p. 20). 
In the previous studies, micropatterning has also been investigated for improving the 
maturation of hiPSC-CMs. In the study carried out by Rao et al. (2013), the cells were 
cultured on grooved substrates. The grooves were 10 μm in width, which is also the width 
of adult CMs (Robertson et al. 2013). By contrast, in the study carried out by Ribeiro et 
al. (2015) the cells were seeded on polyacrylamide gel patterned with 1 % gelatin lines. 
The gelatin lines were 20 μm in width, which is close to the fiber diameters of PET textiles 
used in this study. 20 μm is twice the width of an adult CM (Robertson et al. 2013). In 
this study, the hiPSC-CMs grew along the PET fibers and also extended their width to the 
width of the fibers. Because the fibers had a circular cross-section, the cells growing on 
top of them usually exhibited half circle cross-section. The fiber radius being 10−12.5 
μm, the width of the cells can be calculated as π × r ≈ 31–39 μm, which is actually huge 
compared to the values presented by Robertson et al. (2013). In the future, it might be 
better to use textiles made of thinner fibers (e.g. fiber diameters of 10 μm), so that the 
width of the cells would better match that of the adult CMs. 
In this study, hiPSC-CMs were cultured on five different textiles. The fiber diameters 
were 20−25 μm for all the textiles, but the textile structures varied. However, the scale of 
the cells was so small compared to that of the fibers that the cells hardly ever grew across 
the interlacing points of the textile. In the scale of the cells, the properties of all the textiles 
were similar, and they did not seem to favor any structure over the others. However, the 
amount of cells was very small on all the textiles (the possible reasons for that will be 
discussed in Subchapter 6.3). Some differences between the textile structures could 
probably have been noticed, if more cells would have attached on the fibers. Imaging-
wise a loose structure was more favorable, since, when using brightfield microscopy, 
more light was able to pass through the textiles. For the cells, a tight structure might be 
better, so that they would not fall through the textile onto the multiwell plate’s bottom 
when plating the cells. The multiwell plates’ bottoms were not studied, but it would have 
been a good idea to check if the cells were growing there instead of the textiles. That 
could have also explained why so small amount of cells were found on the textile samples. 
6.3 Challenges During the Study 
During present study, some challenges emerged, one being that only a very small amount 
of cells were found on the textiles. There could be many explanations for that. Firstly, 
there could have been some complications in the dissociation of beating cardiomyocytes. 
Some of the beating areas collected could have been aspirated during the three 
dissociation buffer changes. Also, part of the cells might have died during the step where 
the aggregates were broken down by pressing pipette’s tip against the well plate’s bottom 
and pipetting the solution up and down. The step can be quite rough to the CMs, if it is 
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not done gently enough. Furthermore, maybe there were too small amount of cells used 
in the dissociation to begin with. The size of the beating aggregates varies enormously, 
which means the amount of cells within the aggregates varies. Also, the proportion of 
CMs to the total amount of cells within the aggregates vary. 
Secondly, the small amount of cells could be explained by poor cell attachment. If the 
cells cannot attach on the cell culturing substrate’s surface, they get aspirated during 
medium change. Also, the gelatin coating might have come off, subsequently removing 
the cells from the PET textile’s surface. According to an article, the coating of PET with 
gelatin is difficult, because the surface of PET lacks functional groups, and many attempts 
to immobilize gelatin on PET by physical and chemical methods have been done. An 
approach to a solution that was presented in the article, was an initial surface activation 
of PET with a dopamine coating, onto which the gelatin coating was added. Dopamine is 
the synthetic equivalent of particular adhesive protein of mussels, and it is capable of 
adhering on many different kinds of surfaces including polymers, ceramics, and metals. 
In the study, gelatin-dopamine-PET samples with covalently immobilized gelatin were 
obtained. This coating method was developed especially for cardiovascular applications, 
and it could be applied also to PET textiles. (Giol et al. 2015) Other coatings, such as 
collagen, could be tested, too. All in all, if the coating coming off the textile was the 
reason for the small amount of cells, a better coating without compromising the textile 
topography is needed. 
Lastly, the small amount of cells could mean the cells were growing inside the textile 
structure so that they could not be detected with a microscope. Textiles are three-
dimensional (3D) structures, which makes it possible for the cells to “hide” under the 
fibers. This could be avoided by coating, which forms a film on the textile surface, 
preventing the cells from penetrating the textile. The coating should be thin enough, so 
that the textile topography remains unchanged, but also thick enough so that it plugs the 
routes for cell penetration. 
Other challenges that emerged were related to the imaging of the cells grown on textile 
structures. The textiles were heat treated in order to flatten the structures, but still the 3D 
nature of the textiles was a challenge when using microscopes. The Zeiss Imager.M2 
Axio fluorescence microscope with ApoTome was the best option used in this study, 
because it allowed the creating of a stack of images, which in turn could be used for the 
reconstruction of a Z-projection of the image. Z-axis is the one perpendicular to the image 
plane. Another challenge with imaging was autofluorescence, especially with live/dead 
imaging. Without staining, the cells could not be detected from the textiles, but also the 
stainings were not a good answer to the problem, because there was a disturbing amount 
of autofluorescence. Autofluorescence was also present when imaging the 
immunostained samples, but the effect was not as disturbing as with live/dead imaging. 
Actually, sometimes it was even desired to see the 3D structure as well, in order to 
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understand the locations of the cells within the textiles better. In Figure 6.2, there is a lot 
of autofluorescence which reveals the PET fibers in addition to the cells. 
 
Figure 6.2. hiPSC-CMs growing partly under the PET fibers. In the image, nuclei are 
seen in blue (DAPI), MYBPC is seen in green, and troponin T is seen in red. The fibers 
above the cells are indicated with white arrows. 
In Figure 6.2, the autofluorescence makes it possible to notice, that three of the PET fibers 
are above the hiPSC-CMs, as indicated with white arrows. The parts of the three fibers 
which cross the cells are blurry and mixed with the colors of the cells. Without 
autofluorescence, these areas might have been just blurry, and the cause of it would have 
been uncertain. 
6.4 Future Studies 
In this study, it was demonstrated, that the maturation of hiPSC-CMs was improved by 
culturing the cells on PET textiles. Using a textile topography, the cells were able to 
become more rod-like in shape, and also the sarcomere structures became more organized 
compared to those of hiPSC-CMs grown on flat surfaces. PET probably was not the best 
material choice, because its surface lacks functional groups, thus making the attachment 
of the gelatin coating and cells difficult (Giol et al. 2015). In the future, PET textiles could 
be surface-modificated, for example, with plasma treatment (Alagirusamy & Das 2010, 
p. 452), in order to achieve better attachment of the gelatin coating and cells. Another 
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option is to use a different material and/or coating. Some suggestions for the future studies 
were already discussed in Subchapters 6.1–6.3 (textiles made of biodegradable polymers, 
different coating, and thinner fibers). A few more are introduced in this subchapter. 
In the future, it would be useful to study different time points. In this study, the samples 
were only studied at one time point, at which the hiPSC-CMs had been cultured on the 
textiles for 11 days (27 days of in vitro differentiation and culture). As discussed earlier 
in Subchapter 6.3, one reason why so small amount of hiPSC-CMs were found on the 
textiles could be that the gelatin coating was coming off the textile surface simultaneously 
removing the cells. This effect could be reduced by a shorter culture time. However, a 
longer culture time would allow the hiPSC-CMs to grow and mature more. A study 
carried out by Lundy et al. (2013) investigated the effect of long-term culture on the 
maturation of hiPSC-CMs. The study compared short-term cultured cells (20–40 days of 
in vitro differentiation and culture) to long-term cultured cells (80–120 days). Compared 
to the short-term cultured cells, the long-term cultured cells exhibited significant 
improvements in morphology: the cell size and anisotropy increased, the myofibril 
density and alignment were greater, the sarcomeres were visible by brightfield 
microscopy and there was a 10-fold increase in the fraction of multinucleated hiPSC-
CMs. A longer culturing period could be worth studying with textile structures, too. 
Another suggestion for the future is the differentiation of hiPSCs to CMs directly on 
textile structures. The method has not been very widely studied, but for example 
Prabhakaran et al. (2014) investigated the differentiation of mouse ESCs to CMs on 
electrospun poly(D,L-lactide-co-glycolide)/collagen nanofiber substrates (fiber 
diameters were in the range of 300 ± 65 nm). The study was successful and concluded 
that the nanofibers provided sufficient chemical and mechanical properties for the ESCs 
to grow and differentiate into CMs. However, the maturation of the ESC-CMs was not 
studied. In the method used in this thesis, the cells were differentiated by END-2 method 
on multiwell plates, from which the beating aggregates were collected, dissociated, and 
plated on the gelatin coated textiles. In the END-2 method, the hiPSC colonies are plated 
on top of a mouse endodermal-like (END-2) cell layer. If this differentiation method 
would be used, also the END-2 cells should be first seeded on the textiles. However, the 
presence of other cell types is undesired when a certain cell type is being studied. Thus, 
for differentiating hiPSCs to CMs directly on textiles, some other differentiating method 
not using other cell types would be better. 
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7. CONCLUSIONS 
The aim of this thesis was to find out whether the structural maturation of hiPSC-CMs 
can be enhanced by culturing them on woven PET textiles. These cells were compared to 
hiPSC-CMs grown on coverslips. The studied structural features of the hiPSC-CMs were 
shape, sarcomere orientation, sarcomere length, and multinucleation. 
It was found out that culturing hiPSC-CMs on PET textiles resulted in improved structural 
maturation of the hiPSC-CMs compared to the hiPSC-CMs grown on coverslips. The 
cells grew along the PET fibers, which made them rod-like in shape. By analyzing the 
images taken of the immunostained samples it was found out that, compared to the hiPSC-
CMs grown on coverslips, the hiPSC-CMs grown on textiles had significantly more 
oriented sarcomeres. Also, there were more binucleated cells among the hiPSC-CMs 
grown on textiles. In contrary, there was no significant difference in the sarcomere 
lengths. However, based on shape, sarcomere orientation, and multinucleation, it can be 
argued that the cells grown on textiles were more mature than the cells grown on 
coverslips. 
In this study, there were problems with cell attachment and with cells growing between 
or under the fibers. Next step for the study would be to find a better coating, which would 
enhance the cell attachment without compromising the textile topography. In addition, 
this study focused on the structural maturity, but in the future it would be a good idea to 
also study the functionality of the hiPSC-CMs grown on PET textiles. 
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APPENDIX A: DISSOCIATION BUFFERS 
Table 1. Contents of the dissociation buffer1 (Low-Ca), pH 6.9. 
Volume Ingredient Quantity 
12 ml NaCl 1 M 
0.54 ml KCl 1 M 
0.5 ml MgSO4 1 M 
0.5 ml Na pyruvate 1 M 
2 ml Glucose 1 M 
20 ml Taurine 0.1 M 
1 ml HEPES 1 M 
 pH correction (NaOH)  
 
Table 2. Contents of the dissociation buffer 2 (Enzyme medium), pH 6.9. 
Volume Ingredient Quantity 
12 ml NaCl 1 M 
3 µl CaCl2 1 M 
0.54 ml KCl 1 M 
0.5 ml MgSO4 1 M 
0.5 ml Na pyruvate 1 M 
2 ml Glucose 1 M 
20 ml Taurine 0.1 M 
1 mg/ml Collagenase A  
1 ml HEPES 1 M 
 pH correction (NaOH)  
 
 
  
Table 3. Contents of the dissociation buffer 3 (KB medium), pH 7.2. 
Volume Ingredient Quantity 
3 ml K2HPO4 1 M 
8.5 ml KCl 1 M 
2 mmol/L Na2ATP  
0.5 ml MgSO4 1 M 
0.1 ml EGTA 1 M 
0.5 ml Na pyruvate 1 M 
2 ml Glucose 1 M 
5 ml Creatine 0.1 M 
20 ml Taurine 0.1 M 
 
  
APPENDIX B: DOUBLE-FLUORESCENCE PROTOCOL 
 
  
 
 
 
 
  
APPENDIX C: CYTOSPECTRE RESULTS 
Table 1. Results from the CytoSpectre analysis: hiPSC-CMs grown on PET. 27 cells 
were analyzed. 
Mean orientation 
(°) 
Angular std (°) Mean wavelength = 
sarcomere length (μm) 
Std 
wavelength(µm) 
111.24 0.61 2.04 0.41 
93.34 0.57 1.90 0.16 
92.75 0.69 1.94 0.24 
123.31 0.29 2.19 0.35 
177.97 0.70 2.10 0.43 
99.53 0.59 1.66 0.11 
123.21 0.30 1.86 0.21 
114.04 0.61 1.73 0.16 
121.85 0.68 2.10 0.28 
52.13 0.17 1.79 0.20 
91.92 0.62 1.75 0.18 
108.22 0.40 1.84 0.30 
95.18 0.82 1.84 0.17 
132.82 0.19 1.73 0.20 
93.56 0.68 1.73 0.17 
85.67 0.56 1.76 0.15 
86.52 0.67 1.96 0.19 
93.48 0.25 1.61 0.11 
95.50 0.52 1.95 0.15 
171.58 0.30 2.11 0.40 
1.32 0.47 2.20 0.39 
105.53 0.04 2.48 0.07 
76.43 0.48 1.75 0.22 
106.78 0.69 1.99 0.22 
100.99 0.55 1.95 0.23 
110.64 0.71 1.97 0.24 
84.98 0.49 1.72 0.17 
Average = 101.87 Average = 0.51 Average = 1.91 Average = 0.23 
 
  
  
Table 2. Results from the CytoSpectre analysis: control hiPSC-CMs grown on 
coverslips. 35 cells were analyzed. 
Mean orientation 
(°) 
Angular std (°) Mean wavelength = 
sarcomere length (μm) 
Std wavelength 
(µm) 
43.66 0.37 2.13 0.44 
96.81 0.59 1.90 0.16 
26.92 0.72 1.91 0.31 
51.42 0.74 1.97 0.38 
38.25 0.69 1.80 0.26 
26.38 1.08 1.88 0.35 
53.43 0.71 2.00 0.33 
41.06 1.14 2.02 0.38 
13.32 1.24 1.89 0.39 
59.20 0.67 1.80 0.16 
23.63 1.25 1.86 0.31 
9.15 1.25 1.82 0.30 
31.62 0.59 1.82 0.30 
90.67 0.52 1.71 0.19 
139.73 1.38 1.94 0.40 
85.52 0.50 1.75 0.15 
27.67 1.36 1.80 0.36 
58.10 0.65 1.68 0.21 
48.48 1.21 1.88 0.31 
23.68 0.84 1.86 0.32 
49.56 0.26 2.00 0.37 
64.08 0.75 2.03 0.27 
27.43 0.76 1.79 0.26 
34.21 1.15 1.82 0.34 
39.47 0.68 1.75 0.26 
83.13 0.68 1.83 0.16 
10.14 1.32 1.89 0.32 
11.64 0.66 1.80 0.17 
22.70 0.95 1.87 0.34 
97.07 0.68 1.89 0.22 
6.68 1.04 2.13 0.40 
96.66 0.75 1.83 0.25 
8.90 0.54 2.08 0.40 
13.89 0.50 2.02 0.36 
140.20 1.31 2.07 0.39 
Average = 48.41 Average = 0.84 Average = 1.89 Average = 0.30 
 
  
APPENDIX D: REAGENTS AND THEIR SUPPLIERS AND/OR 
MANUFACTURERS 
Table 1. List of used reagents and their suppliers and/or manufacturers which 
were not mentioned in Chapter 4. 
Reagent/Product Supplier/Manufacturer 
2-mercaptoethanol Life Technologies 
ascorbic acid Sigma 
bovine serum albumin (BSA) Sigma-Aldrich 
fetal bovine serum (FBS) Immunodiagnostic, Biosera 
Glutamax Life Technologies 
KO-DMEM Life Technologies 
KO-SR Life Technologies 
Mitomycin C R&D Systems Bio-Techne, Tocris  
Non-Essential Amino Acids 
(NEAA) 
Life Technologies 
normal donkey serum (NDS) Merck Millipore 
paraformaldehyde (PFA) Sigma-Aldrich 
Penicillin/Streptomycin 
(Pen/Strep) 
City-Lab, Lonza 
phosphate buffered saline (PBS) Life Technologies, Lonza 
TritonX-100 Sigma Aldrich 
 
